CN101896140B - Devices and methods for treating spinal cord tissue - Google Patents
Devices and methods for treating spinal cord tissue Download PDFInfo
- Publication number
- CN101896140B CN101896140B CN200880121075.8A CN200880121075A CN101896140B CN 101896140 B CN101896140 B CN 101896140B CN 200880121075 A CN200880121075 A CN 200880121075A CN 101896140 B CN101896140 B CN 101896140B
- Authority
- CN
- China
- Prior art keywords
- bond material
- multiporous biological
- spinal cord
- damage
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000000278 spinal cord Anatomy 0.000 title claims abstract description 112
- 238000000034 method Methods 0.000 title abstract description 39
- 230000006378 damage Effects 0.000 claims description 101
- 210000001519 tissue Anatomy 0.000 claims description 95
- 239000011148 porous material Substances 0.000 claims description 90
- 239000011241 protective layer Substances 0.000 claims description 47
- 239000000463 material Substances 0.000 claims description 45
- 238000011282 treatment Methods 0.000 claims description 34
- 230000033001 locomotion Effects 0.000 claims description 14
- 102000008186 Collagen Human genes 0.000 claims description 12
- 108010035532 Collagen Proteins 0.000 claims description 12
- 210000004027 cell Anatomy 0.000 claims description 11
- 238000004891 communication Methods 0.000 claims description 11
- 238000001523 electrospinning Methods 0.000 claims description 7
- 210000002950 fibroblast Anatomy 0.000 claims description 7
- 240000004307 Citrus medica Species 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 3
- 102000009027 Albumins Human genes 0.000 claims description 3
- 108010088751 Albumins Proteins 0.000 claims description 3
- 102000016942 Elastin Human genes 0.000 claims description 3
- 108010014258 Elastin Proteins 0.000 claims description 3
- 206010063560 Excessive granulation tissue Diseases 0.000 claims description 3
- 229940072056 alginate Drugs 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- 238000009826 distribution Methods 0.000 claims description 3
- 229920002549 elastin Polymers 0.000 claims description 3
- 210000001126 granulation tissue Anatomy 0.000 claims description 3
- 229920002674 hyaluronan Polymers 0.000 claims description 3
- 229960003160 hyaluronic acid Drugs 0.000 claims description 3
- 229920000151 polyglycol Polymers 0.000 claims description 3
- 239000010695 polyglycol Substances 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 238000007639 printing Methods 0.000 claims description 2
- 239000012778 molding material Substances 0.000 claims 1
- 206010030113 Oedema Diseases 0.000 abstract description 20
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 208000015181 infectious disease Diseases 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 208000014674 injury Diseases 0.000 abstract description 7
- 230000008961 swelling Effects 0.000 abstract description 3
- 230000006835 compression Effects 0.000 abstract description 2
- 238000007906 compression Methods 0.000 abstract description 2
- 230000001010 compromised effect Effects 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 description 82
- 238000002560 therapeutic procedure Methods 0.000 description 21
- 208000027418 Wounds and injury Diseases 0.000 description 15
- 210000003205 muscle Anatomy 0.000 description 13
- 241000700159 Rattus Species 0.000 description 12
- 238000007789 sealing Methods 0.000 description 12
- 230000035939 shock Effects 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 206010052428 Wound Diseases 0.000 description 9
- 239000011230 binding agent Substances 0.000 description 9
- 229920001436 collagen Polymers 0.000 description 9
- 239000007789 gas Substances 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 208000034656 Contusions Diseases 0.000 description 8
- 230000009519 contusion Effects 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- 210000001951 dura mater Anatomy 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 238000011084 recovery Methods 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 230000005021 gait Effects 0.000 description 6
- 206010033675 panniculitis Diseases 0.000 description 6
- 230000036961 partial effect Effects 0.000 description 6
- 208000020431 spinal cord injury Diseases 0.000 description 6
- 210000004304 subcutaneous tissue Anatomy 0.000 description 6
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 5
- 210000003141 lower extremity Anatomy 0.000 description 5
- 238000002595 magnetic resonance imaging Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 102000012422 Collagen Type I Human genes 0.000 description 4
- 108010022452 Collagen Type I Proteins 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 208000028867 ischemia Diseases 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000007920 subcutaneous administration Methods 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 206010015548 Euthanasia Diseases 0.000 description 3
- 229920000954 Polyglycolide Polymers 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000004900 autophagic degradation Effects 0.000 description 3
- 238000005266 casting Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 210000003194 forelimb Anatomy 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000002427 irreversible effect Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 229920001610 polycaprolactone Polymers 0.000 description 3
- 239000004632 polycaprolactone Substances 0.000 description 3
- 239000004633 polyglycolic acid Substances 0.000 description 3
- 239000004626 polylactic acid Substances 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000037273 Pathologic Processes Diseases 0.000 description 2
- 206010058046 Post procedural complication Diseases 0.000 description 2
- 208000035965 Postoperative Complications Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229940096422 collagen type i Drugs 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 238000002224 dissection Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 238000002684 laminectomy Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 230000007171 neuropathology Effects 0.000 description 2
- 230000000324 neuroprotective effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000009054 pathological process Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- VHRSUDSXCMQTMA-PJHHCJLFSA-N 6alpha-methylprednisolone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 VHRSUDSXCMQTMA-PJHHCJLFSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002329 Aneurysm Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010021137 Hypovolaemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000489861 Maximus Species 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 208000003926 Myelitis Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010049654 Spinal cord infection Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N ethyl butyrate Chemical compound CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- 229960005082 etohexadiol Drugs 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000007849 functional defect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 108010084652 homeobox protein PITX1 Proteins 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229960004584 methylprednisolone Drugs 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 230000002632 myometrial effect Effects 0.000 description 1
- 230000006576 neuronal survival Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000010410 reperfusion Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000011268 retreatment Methods 0.000 description 1
- 229940116351 sebacate Drugs 0.000 description 1
- CXMXRPHRNRROMY-UHFFFAOYSA-L sebacate(2-) Chemical compound [O-]C(=O)CCCCCCCCC([O-])=O CXMXRPHRNRROMY-UHFFFAOYSA-L 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000000701 subdural space Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000010408 sweeping Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012719 thermal polymerization Methods 0.000 description 1
- 230000030968 tissue homeostasis Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000009724 venous congestion Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/916—Suction aspects of the dressing specially adapted for deep wounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01021—Non-adhesive bandages or dressings characterised by the structure of the dressing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/74—Suction control
- A61M1/75—Intermittent or pulsating suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/96—Suction control thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1003—Spinal column
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Cardiology (AREA)
- Medical Informatics (AREA)
- Neurology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Surgical Instruments (AREA)
Abstract
The present invention provides devices and methods that treat damaged spinal cord tissue, such as spinal tissue damaged by disease, infection, or trauma, which may lead to the presence of swelling, compression, and compromised blood flow secondary to interstitial edema.
Description
Invention field
The present invention relates generally to the apparatus and method of the myeloid tissue that adopts negative pressure treatment damage or infringement, and more particularly, but be not exclusively, relate to being used for the treatment of to experience and can recover or the apparatus and method of the myeloid tissue of irrecoverability damage.
Background of invention
The treatment of the myeloid tissue that relates to anatomy, physiology and the pathological process special concern damage of spinal cord attitude or damage.The three dimensional structure anatomy of neuroprotective unit (its function depends on the special space relation with other neuron and other sustenticular cell) concern both with microanatomy and maintain suitable oxygen enrichment blood flow and wherein the homogeneous phase substrate of neuronal survival be myeloid tissue survive and function necessary.In addition, cord cell can not be regenerated and given prominence to for making each possible neuronic survival reach demand to greatest extent.Due to for example these reasons, the space sickness Neo-Confucianism for the treatment of spinal cord attitude open and closed system is the problem of special concern.
In the clinical problem that threatens myeloid tissue's survival is arranged, it is main controlling edema of spinal cord, infection and blood supply.Spinal cord responds to wound and damage by the interstitial edema of collecting significant quantity.Because spinal cord is closed in the space (dura mater and ridge pipe) of sealing, the blood flow that edema causes spinal cord is with the compression of performance nutrition and weaken, and this physiology that damages widely spinal cord recovers and usually therefore cause the development and death of spinal cord lesion.Comprise medicine for reducing the current available treatment of edema, for example glucocorticoid (dexamethasone, prednisone, methylprednisolone), diuretic and decompression widely.Yet, for the unfavorable conditions of these treatments, comprise irregular and unpredictable results, medicine complication, infection and postoperative complication.
Due to disastrous consequence and the high likelihood of spinal cord infection with the fast propagation of edema, to demand quick and that effectively treat, be also extremely important.There is at present the successful methods of the pathological changes of several available treatment invasion and attack spinal column inner chambers, spinal cord essence and surrounding structure.When organizing of health other places is available, change dressings while processing, spinal cord is because its unsettled structure, the potentiality that infect tendency and lesion development are not suitable for the type treatment.Illustrate on evidence the inflammation of spinal cord injury and other pathological changes and immunne response are had with initial damage or injure identical or than initial damage or the more long-term consequence of injury.Spinal cord causes the damage of hypoxia and the mediation of local ischemia/reperfusion to replying of the Oligemia that is secondary to edema.These damages cause neuro pathology's sequela, and the latter causes again the unfavorable result of spinal cord injury to a great extent.
In addition, spinal cord need to continuously be supplied with the oxygen enrichment blood flow with performance function and survival.Interrupting blood flow to spinal cord fully in a few minutes, cause irreversible spinal cord injury.Yet, spinal cord can survive and the blood flow that certainly reduces in recover the period more extended.The focus zone (focal areas) that spinal cord is described on evidence can keep ischemia with relative nonfunctional a couple of days and still can recover.This discovery has caused the concept in ischemia zone, is called penumbra Huo Yun district (halo zone), and it is around the zone of irreversible damage.The secondary phenomenon in ischemia zone (secondary phenomena) is to discharge by the local excitatory neuron toxin discharged of the neuron of damage, variation and the edema of focal zone blood flow.
The angiological pathology of spinal column can be following result: because perfusion pressure reduces, cause the angiorrhexis to local spinal cord zone coup injury, or make to flow to the hematopenia of cord cell by compressing adjacent tissue; Such as atherosclerosis, aneurysm, inflammation etc. of spinovascular intrinsic disease; From other places for example heart be deposited on the sparse thrombosis in the spinal cord blood vessel.
In the situation that the spinal column internal hemorrhage, the hemorrhage fritter material usually used as dissect the volume growth of (pressure dissection) with pressure starts and causes the myeloid tissue of displacement and compressing vicinity.Edema in the hemorrhage oppressed tissue of vicinity on every side can cause by the more large-area myeloid tissue of infringement the deterioration of mass effect and clinical condition.Edema in contiguous spinal cord can cause usually through the deterioration of 12-72 hour visible carrying out property.Edema occurs in one week after the spinal column internal hemorrhage and usually make prognosis become even worse, especially in aging people.Perihematoma organize replaced and compressing, but not necessarily fatal infringement.Improvement can be absorbed due to hematoma again, contiguous decrease in edema and the organized renewing function of getting involved obtain.
Treat these diseases and made people's disappointment.It may be useful that the decompression of spinal cord prevents in the case of irreversible compressing at some.Reagent for example other penetrating agent of mannitol and some can reduce the spinal column internal pressure caused by edema.Steroid has uncertain value in these cases and current built view adopts hyperbaric oxygen.
Therefore, although to injured skin and subcutaneous tissue apply negative pressure (or negative pressure) therapy confirm with traditional method relatively Healing Rate increase and (set forth in No. the 2003/0225347th, 2004/0039391 and 2004/0122434, No. the 5645081st, 5636643,7198046 and 7216651, US patent and the disclosed application of US, its content is attached to herein by reference), still need to be specially adapted to the apparatus and method of special myeloid tissue.
Summary of the invention
The invention provides the myeloid tissue that adopts negative pressure (or negative pressure) treatment damage, for example, by the apparatus and method of the myeloid tissue of disease, infection or wound infringement, described disease, infection or wound can cause being secondary to the existence of blood flow of swelling, compressing and the minimizing of interstitial edema.For example, spinal cord can be by causing recovering or the blunt force injury damage of expendable damage.
In one aspect, the invention provides the method for the myeloid tissue that adopts the negative pressure treatment damage.The method comprises porous material is placed in to approach between the myeloid tissue of myeloid tissue with the one or more holes at porous material and damage of damaging provides gas communication (gaseouscommunication).Porous material can be sealed in the myeloid tissue that approaches damage on the spot, so that the zone of the myeloid tissue's maintenance negative pressure that maintains damage to be provided around the myeloid tissue in damage.Porous material can be connected by the vacuum system that operationally with myeloid tissue in damage, produces negative pressure, and the vacuum system started provides negative pressure in the myeloid tissue of damage.Can in the myeloid tissue of damage, keep negative pressure to be enough to reduce at spinal cord the time of edema.For example, negative pressure can remain on lower than the about 25mm Hg of atmospheric pressure.The method also can be included in the myeloid tissue of damage settles protective layer seal protection layer in the tissue of the myeloid tissue that approaches damage, for the myeloid tissue in damage, keeps negative pressure.The form that protective layer can be placed in the autoadhesion sheet (self-adhesive sheet) in the myeloid tissue of damage provides.In such a case, the step of seal protection layer can comprise and seal deadlockedly and make the autoadhesion sheet adhere to the tissue around the Spinal Cord tissue, between described and tissue around the myeloid tissue of damage, to form sealing.
In yet another aspect, the invention provides the device that is used for the treatment of the Spinal Cord tissue.But this device can comprise the biology bond material of porous for example opens chamber (open-cell) collagen protein, it has the pore structure that is shaped to allow carry out gas communication between one or more holes of porous material and the myeloid tissue for the treatment of.The biological combinableness matter of porous material can avoid needing second method to remove porous material.(as used herein term " biological combinative " be defined as describing can be positioned over for a long time in patient body and can be by refigure, the material reuptaking, dissolve and/or otherwise assimilate or modify).Device also comprises the vacuum source for generation of negative pressure; Vacuum source can be configured for the distribution negative pressure to myeloid tissue with the mode of the gas communication of porous material.Porous material at least can have on the surface of the selection of porous material enough little hole to prevent from being organized in wherein growth.In addition, porous material at least can have the pore size that is less than fibroblast and cord cell size on the surface of the selection of porous material, and can have in the position except selected surface the pore size that is greater than fibroblast and cord cell size.The pore size of porous material can be even as big as the protein motion that allows the albumin size to pass through.And, but the biology bond material of porous can comprise at least one sealed surface to prevent that negative pressure from therefrom transmitting.Device also can comprise the protective layer in the myeloid tissue that is shaped to cover damage, under the protective layer at the Spinal Cord tissue, to keep negative pressure.
Therefore, the progress the invention provides for making pathological process reduces to minimum, makes the destruction of physiology spinal cord integrity reduce to minimum and make the interference of spinal cord blood flow and nutrition is reduced to minimum apparatus and method.By reducing edema of spinal cord and spinal column internal pressure, the risk that spinal cord forms hernia and infringement can be reduced to minimum.In addition, the present invention is convenient to remove the toxin that in medium, catabolite and enhancing spinal cord, the neuro pathology of inflammation and tissue replys.
The accompanying drawing summary
When read in conjunction with the accompanying drawings, above-mentioned general introduction and the following detailed description of the preferred embodiments of the invention will get the best understanding, wherein:
Fig. 1 illustrates the partial sectional view of the example arrangement of apparatus of the present invention before applying negative pressure on the spot;
Fig. 2 illustrates the partial sectional view of Fig. 1 when applying negative pressure;
Fig. 3 illustrates and is presented at the partial sectional view of Fig. 1 and 2 that the spinal cord surrounding tissue applies the effect of negative pressure;
Fig. 4 illustrates and comprises on the spot the subcutaneous partial sectional view that is configured in second example arrangement of the present invention of epispinal rigidity or semi-rigid protective layer;
Fig. 5 illustrates and comprises on the spot the subcutaneous partial sectional view that is configured in the 3rd example arrangement of the present invention of epispinal flexible protective layer;
Fig. 6 for example understands that the BBB scoring is as the time function that is exposed to the control animal of recoverable spinal cord blunt wound;
Fig. 7 for example understands the time function of BBB scoring as the animal that is exposed to recoverable spinal cord blunt wound and processes by negative pressure;
Fig. 8 for example understands the spinal cord sectional area as the time function of the control animal that is exposed to expendable spinal cord blunt wound;
Fig. 9 for example understands the spinal cord sectional area as the time function of the animal that is exposed to expendable spinal cord blunt wound and processes by negative pressure; With
Figure 10 illustrates the porous material had for the multiple structure of negative pressure device of the present invention.
Detailed Description Of The Invention
While mentioning accompanying drawing now, wherein same parts adopt identical numbering in the text, the present invention relates to adopt the apparatus and method of the myeloid tissue of negative pressure (or negative pressure) treatment damage, wherein " damage " tissue be defined as comprising be damaged, damage or with any alternate manner weakening for example due to the tissue of wound, disease, infection, postoperative complication or the damage that for example other pathological process causes.More particularly, apparatus and method of the present invention can realize more than any reason for example mentioning the treatment of the Secondary cases spinal cord essence edema of reason; Around spinal cord, any gap comprises the treatment of subdural space/epidural space; With the treatment raise due to any reason spinal column internal pressure that for example above-mentioned reason causes.
The example arrangement of negative pressure medullotherapy device 100 of the present invention can comprise for the vacuum source 30 of negative pressure, Fig. 1-3 are provided to the porous material 10 that is arranged in contiguous spinal cord 7 by pipeline 20.In this respect, can construct porous material 10 to transmit and the distribution negative pressure to spinal cord 7.Medullotherapy device 100 can be applied to the patient by the myeloid tissue 7 that porous material 10 is placed in to contiguous damage, between the myeloid tissue 7 with the one or more holes at porous material 10 and damage, provides gas communication.Pipeline 20 can be connected in porous material 10 at the far-end 22 of pipeline 20, and porous material 10 can seal on the spot by the stitching thread 8 in skin and subcutaneous tissue 2, around the myeloid tissue 7 in damage, to provide a zone for keeping negative pressure.The near-end 24 of pipeline 20 can be connected to vacuum source 30 with porous material 10 and the vacuum source 30 of being operably connected, and for the myeloid tissue 7 in damage when starting vacuum system 30, produces negative pressure.
Forward more detailed Fig. 1 to, patient's surrounding tissue that the example arrangement of negative pressure medullotherapy device 100 of the present invention shows at partial sectional view is illustrated on the spot.The tissue of example explanation comprises skin and subcutaneous tissue 2, muscular tissue for example trapezius muscle 3 and erector spinae 4, vertebra 5, transverse process 6 and spinal cord 7.To lead to spinal cord 7 in order providing, can to lack a part of vertebra 5.For example, spinous process can lack due to operation dissection, disease or damage.Porous material 10 is for example opened the subcutaneous space that the chamber collagen material for example can be placed in the contiguous myeloid tissue 7 with negative pressure treatment, with the edema that reduces parenchymal tissue with improve physiological function.Except opening the chamber collagen material, porous material 10 also can comprise polyglycolic acid and/or poly-lactic acid material, synthetic polymer, flexible sheets sample sieve aperture, open the chamber foam of polymers, foam segment, porous chips, polyvinyl alcohol foam, polyethylene and/or polyester material, elastin laminin, hyaluronic acid, alginate, polyglycols citron acid esters, poly butyric ester, poly-hydroxyfumaric acid ester, PTMC, polyglycereol sebacate (sebecate), the poly-anhydride of aliphatic/aromatics or other suitable material, and for example can pass through electrospinning (electropinning), the combination of any above-mentioned material of casting or printing preparation.Such material comprises chitosan solution (1.33% weight/volume in 2% acetic acid, 20ml cumulative volume), and it can be poured in the mould of suitable size.Then make solution under-70 ℃ freezing 2 hours, then be transferred in lyophil apparatus and apply vacuum 24 hours.Described material can, by 2.5%-5% glutaraldehyde steam crosslinked 12-24 hour (or passing through ultraviolet radiation 8 hours), provide casting porous material 10.
In addition, porous material 10 can be by casting polycaprolactone (PCL) preparation.The chloroform that polycaprolactone can mix with sodium chloride (1 part of caprolactone is to 10 parts of sodium chloride) and be placed in enough volumes is with dissolved constituent.For example, the solution of 8ml can be poured in the container of suitable size and shape and make it dry 12 hours.Then can make sodium chloride leach in water 24 hours.
Also can use the electrospinning material for porous material 10.It for the preparation of the preparation of electrospinning porous material 10 and an illustration of method, is the Collagen type I adopted with the ratio existence of 76%: 4%: 20% (weight): ch.-6-s (CS): the combination of poly-1,8-ethohexadiol citron acid esters (POC).Two kinds of solvents are for collagen/CS/POC.Make CS soluble in water and collagen and POC are dissolved in 2,2,2-trifluoroethanol (TFE).Then use the solution of 20% water/80%TFE solution (volume/volume).For electrospinning, will contain collagen: CS: the solution of POC mixture is placed in the 3ml syringe that is equipped with the 18Ga pin.Syringe pump (New Era Pump Systems, Wantaugh, NY) is for being delivered to the pin end by solution with the speed of 2.0ml/hr.10-20kV voltage is provided and is applied to distance between the pin of 15-25cm (anode) and ground connection catcher (negative electrode) through high voltage power supply (HV PowerSupply, Gamma High Voltage Research, Ormond Beach.FL).Then make the crosslinked and thermal polymerization (80 ℃) of this material and glutaraldehyde (II level, 25% solution) 48 hours.Also can the initial concentration in HFIP (HFP) be 80mg/ml collagen starts electrospinning Collagen type I porous material 10, then adopt and combine identical electrospinning condition with collagen: CS: POC.
A kind of other method for generation of porous material 10 is to adopt the thermal inkjet-printing technology.But biology bond material for example collagen, elastomer, hyaluronic acid, alginate and polylactic acid/polyglycolic acid copolymer can be printed.For example, be dissolved in 0.05% acetic acid, then be diluted with water to type i collagen (the Elastin Products Co. of 1mg/ml, Owensville, MO) can be printed, as sodium alginate (Dharma Trading Co., San Raphael, CA) 1mg/ml is printable the same in water.Type i collagen (2.86mg/ml is in 0.05% acetic acid) and polylactic acid/polyglycolic acid (PURAC America, Blair, NE) (14.29mg/ml is (SigmaAldrich, St.Louis MO) in tetraethylene glycol (TEG)) also can be printed.Comprise motor and can be installed in platform for the spool bed (carriage) of ink powder tube (cartridges) from the hardware of Hewlett Packard 660c printer.Then the height of capable of regulating hardware more than platform printed for layering.
For example, yet porous material 10 can or have larger pore size (being greater than the size of fibroblast and cord cell) in any other position of the porous material 10 do not contacted with myeloid tissue 7 in the inside of porous material 10.For example, porous material 110 can comprise the multiple structure with non-inside grown layer (non-ingrowth layer) 112, it has enough little pore size and wherein grows and alternative spinal cord to prevent from being organized in, and can there is the additional layer 114 of different materials, it has the relative larger pore size with non-inside grown layer 112 contacts.
Perhaps, porous material 10 can be uniform aspect composition and/or morphology.Position at the interface away from spinal cord 7, porous material 10 can have the pore size that promotes to form granulation tissue even as big as other tissue in the surrounding space at spinal cord 7, and the zone promotion formation granulation tissue that spinal cord breaks for example occurs.In addition, it is sealed in case stop-pass is crossed the surface transmission negative pressure of such sealing that porous material 10 can have one or more sides or the surface of porous material 10 wherein, and have the structure on the surface that at least one can be by its transmission negative pressure simultaneously.Can there be the tissue of priority treatment in such structure of porous material 10 and process other side in a side of porous material 10.For example, non-tight interface processing when, the essence of spinal cord 7 can be with a side of porous material 10.
In order to porous material 10, to transmit negative pressure to be distributed to spinal cord 7, pipeline 20 can be connected with the mode of porous material 10 with gas communication directly or indirectly at the far-end 22 of pipeline 20.For example, the far-end 22 of pipeline 20 can be embedded in porous material 10 or can be placed on porous material 10.The far-end 22 of pipeline 20 also can comprise one or more perforation to help to porous material 10 and spinal cord 7 transmission negative pressure.Pipeline 20 can extend by the opening in skin and subcutaneous tissue 2, and its available stitching thread 8 provides sealing around being fixed on pipeline 20 around pipeline 20 with help.The near-end 24 of pipeline 20 can be operably connected to vacuum source 30, and vacuum pump for example, to provide the negative pressure to porous material 10 and spinal cord 7 transmission by pipeline 20.
In order to contribute to keep the negative pressure of spinal cord 7, can provide flexible protective layer/sheet 50 or rigidity (or semi-rigid) protective layer 40 approaching spinal cord 7 places, so that a zone that can keep negative pressure, Fig. 4,5 to be provided around spinal cord 7.Specifically, with reference to Figure 4 and 5, the zone 48,58 of tissue to seal in spinal cord 7 and restriction around porous material 10 that approaches spinal cord 7 by protective layer 40,50 is adhered to can provide protective layer 40,50 on spinal cord 7 and porous material 10.For example, protective layer 40,50 can adopt binding agent 42 for example Fibrin Glue adhered to vertebra 5, muscular tissue 4 and/or other suitable tissue.Binding agent 42 can comprise autohemagglutination rubber alloy (auto-polymerizing glue) and/or can desirably comprise filler, so that the binding agent 42 with enough volumes to be provided, so that binding agent 42 can meet the shape of the potential irregular surface of binding agent 42 contacts.Binding agent 42 can be used as component separately or provides as the part of protective layer 40,50, so that half gluing protective layer 40,50 to be provided.For example, protective layer 50 can comprise flexible half sheet adhesive, and it comprises suitable binding agent on its one or more surfaces.
For flexible protective layer 50, the outward flange of flexible protective layer 50 or edge can twist in spinal cord 7 times (or to) spinal cord 7 is rolled.Perhaps, but flexible protective layer 50 rolling off spinal cord 7, so that then following (side is facing to the porous material 10) of protective layer 50 can contact with muscle and soft tissue on every side with vertebra 5, Fig. 5.If flexible protective layer 50 is rolled for 7 times at spinal cord, binding agent 52 can be coated on the outside of the protective layer 50 between protective layer 50 and vertebra 5, muscle and soft tissue on every side so, to help to promote gas-tight seal.If flexible protective layer rolling off spinal cord 7, binding agent can be applied to the following of protective layer 50 between protective layer 50 and vertebra 5 and on every side muscle and soft tissue to produce gas-tight seal.
Negative pressure can the transmission of the cooperation between protective layer 40,50 and pipeline 20 below protective layer 40,50.Specifically, protective layer 40 (or flexible protective layer 50) can comprise the vacuum valve 43 be connected with the far-end 22 of pipeline 20, so that the gas communication between pipeline 20 and the space 48 above the following spinal cord 7 of protective layer 40, Fig. 7 to be provided.Perhaps, protective layer 50 (or protective layer 40) can comprise the path 52 that pipeline 20 passes through so that the far-end 22 of pipeline 20 is configured in below protective layer 50 in the space 58 above spinal cord 7 and with space 58 gas communications, Fig. 5.
Aspect its another, the present invention also provide for by for example at the device of Fig. 1-5 graphic extension, adopt the method for the myeloid tissue of negative pressure treatment damage.Specifically, method can comprise the myeloid tissue 7 that porous material 10 is placed in to approaching damage, between the myeloid tissue 7 with the one or more holes at porous material 10 and damage, provides gas communication.Porous material 10 can be sealed on the spot in the myeloid tissue 7 that approaches damage, with the zone that provides for the myeloid tissue 7 in damage, to keep negative pressure around the myeloid tissue 7 in damage.In this respect, but muscle 3,4 and subcutaneous tissue loosely the top of porous material 10 with by skin 2 with sew up the pipeline 20 that the skin 2 of sealing leaves away and reaccees.The dressing of another gas-tight seal can optionally be placed in suture location to promote gas-tight seal.Porous material 10 can be operably connected to vacuum system 30, for the myeloid tissue 7 in damage, produces negative pressure, and vacuum system 30 is actuated to provide negative pressure in the myeloid tissue 7 of damage.For example, negative pressure can be maintained at about the Hg lower than atmospheric pressure 25-75mm.The time that the myeloid tissue 7 that negative pressure can be maintained at damage is enough to reduce the edema of spinal cord 7 or controls the spinal fluid seepage.In addition, the myeloid tissue 7 that negative pressure can be maintained at damage is enough to regulate the time of myeloid tissue 7, and the stage reduced to reach recovery from illness and antibacterial numeration for example, can be successfully so that accept Retreatment (lobe (flaps), skin transplantation).Method can be used at least 4 hours, or can use many days.When vacuum-therapy finishes, can remove stitching thread 8 and make skin 2 opening again.Then can remove porous material 10 and again sew up sealing skin 2.
Method also can comprise that the tissue that is placed in above the myeloid tissue 7 of damage by protective layer 40,50 and protective layer 40,50 is sealed in to the myeloid tissue 7 that approaches damage keeps negative pressure for the myeloid tissue 7 in damage.The step that protective layer 40,50 is sealed in to the tissue around the myeloid tissue 7 of damage can comprise by protective layer 40,50 deadlocked seal and adhere to the tissue around the myeloid tissue 7 of damage.Protective layer 50 can provide from the form of attachment flaps (self-adhesive sheet) 50, and it can be positioned at above the myeloid tissue 7 of damage.In such a case, the step of seal protection layer 50 can comprise by from attachment flaps 50 deadlocked seal and adhere to the tissue around the myeloid tissue 7 of damage, between the tissue around the myeloid tissue 7 of sheet 50 and damage, to form and to seal.In addition, operationally with the form of gas communication, connect vacuum system 30 and can comprise with the step of porous material 10 vacuum valve 42 that is connected vacuum system 30 and protective layer 40.
Embodiment
Spinal Cord Injury in Rats and negative pressure expose
Experiment 1
Implement series of experiments and rat is dampened to the effect of the rear spinal cord of damage to determine negative pressure.In first animal scheme, obtain 250-300 gram Sprague Dawley rat and set up contusion of spinal cord model and confirmation.Produce the method for damaging and estimate recovery and be based on Wrathall etc., the contusion of spinal cord damage of rat: classification, can repeat, the generation of damage group, experimental neurology (Spinal Cord Contusion in the Rat:Production of Graded, Reproducible, Injury Groups, Experimental Neurology 88,108-122 (1985)) description of contusion of spinal cord damage in.The development surgical technic is for the spinal cord that exposes anesthetized rat and lean on body by the circle that falls 10 gram weight through glass tubing from 5cm height and produce consistently and dampen damage.The half rat is untreated matched group, and second half have be exposed to 4 hours negative pressure (lower than atmospheric pressure 25mm Hg) the contusion zone.Yet the degree of damage does not produce remarkable damage (they recover rapidly) in control animal, and therefore can not compare treatment group animal and control animals.
Set up second scheme, wherein on spinal cord, suffer more serious damage (10 gram weight fall from higher height-7.5cm).28 large (300 gram) Sprague Dawley rats are purchased a period of time and are made it to adapt to the condition of supporting of closing.On operation same day, make animal calm and scrape hair at its back and clean with for operation.Make the midline incision for preparing through spinal column extend and expose darker muscle of back with fascia by skin and subcutaneous tissue and the large flesh of skin (maximus muscle).Be located away from center line paired muscle the offside retraction (retracted laterally) that center line (trapezius muscle and hiding latissimus dorsi m.) is joined.Deep ' posture ' muscle for example is connected to ridge oblique (spinotrapezius) and/or the erector spinae (sacrospinal) itself of spinal bone structure and also retracts at center devision offside.This has exposed spinous process and some hiding transverse process.In the T7-T9 level, remove spinous process between two continuous vertebras and little transversospinales, expose spinal cord surface (dura mater).Implement laminectomy at T-8.Method based on Wrathall etc., make spinal stabilization at T-7 and T-9 and highly fall 10 gram weight to produce moderate spinal cord injury from 7.5cm.5 animals died from respectively its initial operation same day (3 matched group and 2 in the vacuum-therapy group), and 1 animal dead in the early stage matched group of experiment, entered latter 2 days remaining 22 animals of experiment.While finishing to experiment, 11 animals have been randomized to either each group in matched group and 25mm Hg vacuum group.
For control rats, do not provide treatment, and damage is sewn sealing.For vacuum-therapy group rat, polyvinyl alcohol vacuum pack system (Vacuseal Plus, Polymedics, Belgium) is placed on spinal cord and skin is sewn sealing, and vacuum tube passes through incision extension.After within 1 day, postponing, to each animal of vacuum-therapy group, apply lower than the vacuum (negative pressure) of atmospheric pressure 25mm Hg 4 hours.When this time finishes, make animal again calm, remove vacuum pack system, and skin incision is sewed up again with monofilament linea suturalis.
Check cutting part every day.Check that animal self drains the sign of its bladder capacity.Any animal that can not drain is accepted manual auxiliary facilities 3 times with 8 hours intervals every day.Check autophagy metabolism (auto-cannibalism), decubital ulcer and the degree of hydration (squeezing test (pinchtest)) of animal every day.Animal is closed to be supported in soft sized (soft shavings) so that the probability of decubital ulcer development reduces to minimum.Food is placed in the cage bottom so that edible.Animal is checked the recovery of hind leg motor function every day, and each hind leg is adopted to improved Tarlov marking system, and (0=is without motion, without load-bearing; The 1=light exercise, without load-bearing; 2=frequently moves, without load-bearing; The 3=load-bearing, the 1-2 step; The defective walking of 4=; The flawless walking of 5=).Animal is tested (they can no longer can be held and slip down from this plane in this angle) on clinoplain by every day, and checks hind leg grip (grip strength).Animal latter 14 days of operation by euthanasia and remove spinal column and carry out histological examination.
Experimental result provides in table 1 and 2, and " 0 " day is the operation same day.Several animals present minimum damage/defect and during weight falls, enough damages can not be arranged.( control animal 1,2,11 and treatment group animal 3,9,10.Referring to table 1 and 2).2 animals present serious/damage and not recovery fully.(control animal 5 and treatment group animal 2.Referring to table 1 and 2).Be sure of these remaining whole 7 control animals and 7 treatment group animals there is enough damages but be serious/damage fully.
For the purpose of analyzing, think that animal " recovery " is that it reaches at least 4/4 and scores that day.In 7 control animals, in the time of postoperative 8 days in one's hands, 3 animals do not return at least 4/4 score (right lower limb/left lower limb-defective walking (walking with deficit)).( animal 3,6,7, table 1).In remaining 4 control animals ( animal 4,8,9,10), 3 animals reached 4/4 at the 4th, 6 and 13 days scores, and 1 animal has reached 4/5 at the 7th day and scores.Therefore, 4 control animals are at average 7.5+/reached at least 4/4 in-3.35 days to score.For the treatment group animal, whole 7 animals ( animal 1,4,5,6,7,8,11) are at average 5.14+/reached at least 4/4 in-1.24 days to score.Therefore, it is evident that the spinal column to damage applies the speed (p=0.059) that 25mm Hg vacuum can increase functional rehabilitation.
table 1. matched group
table 2. vacuum-therapy group
Experiment 3
Formulate the another kind of still scheme of the more serious damage that will cause irrecoverable (permanent) functional defect that wherein produces.Dampen the technology of the employing NYU contusion of spinal cord system of example based on W.M.Keck neuroscience joint study center (Center for Collaborative Neuroscience)-spinal cord injury research project (The Spinal Cord Injury Project) exploitation.These systems (being called at present " MASCIS ") are set up and can pass through the BiologyDepartment at Rutgers University (W.M.Keck neuroscience joint study center (Center for Collaborative Neuroscience) by conventional, Piscataway (Piscataway), New Jersey (New Jersey)) buy.
In above-mentioned experiment, animal is fixed the operation according to body weight, but animal determines according to the age to be performed the operation in this experiment.Long Evans hooded rat was performed the operation so that damage the seriousness standardization when 77 day age.Before operation between 1 and 6 day, some animals are by calm and be transported to the toy MRI imaging mechanism (the SmallAnimal MRI Imaging Facility of Wake Forest University School ofMedicine) of Wake Forest medical college, and adopt Bruker Biospin Horizontal Bore 7Tesla toy scanning device (Etta woods root (Ettlingen), Germany (Germany)) at T9-T10 horizontal sweep spinal cord.Then make the animal be scanned recover in anesthesia in the cage of heating.At the anesthetized animal on the same day of operation, and back part of animal is scraped hair and is adopted depilatory cream.Adopt aseptic technique, in the T9-T10 level, implement laminectomy.Adopt NYU contusion of spinal cord system impacting body (impactor) and use the 10 gram clubs that highly fall from 25mm to clash into spinal cord at T9-T10.The animal of matched group has the otch of the sealing sewed up, and animal is recovered in the cage of heating.For the treatment group animal, polyvinyl alcohol vacuum pack system (VersaFoam, Kinetic Concepts, Inc., San Antonio, TX) is placed on spinal cord, myometrial suture sealing, and apply 25mm Hg vacuum lower than atmospheric pressure 25mm Hg 8 hours.After this time, the treatment group animal, by again calm, is opened otch, removes vacuum pack system and again sews up sealing cut.If the animals received Postoperative MRI, animal is scanned 8 hours after shock.
Functional rehabilitation is marked with BBB, from 22 comments minute of W.M.Keck neuroscience joint study center (Center for Collaborative Neuroscience), is estimated.(table 3).Monitored 21 days of animal, then through being exposed to the CO of lethal dose<sub TranNum="165">2</sub>make euthanasia.Bladder is pushed by every day and the sign of the monitored autophagy metabolism of animal, decubital ulcer, skin lesion etc.Remove and anyly present the animal of autophagy metabolism sign and make euthanasia in research.Decubital ulcer and skin lesion are when appropriate and seek advice from ARP veterinary work personnel and treated.Although this nursing is arranged, in the process of this experiment, some animal deads, and other animal is because other problem is left out.<tables TranNum="166" num="0001"> <table TranNum="167"> <tgroup TranNum="168" cols="1"> <colspec TranNum = "169" colname = "c001" colwidth = "100 % "/> <tbody TranNum="170"> <row TranNum="171"> <entry TranNum="172" morerows="1">, value ,,,, ,,,, ,,,, , condition, , 0, , , there is no observable hind limb movement , , 1,, , slight movement of one or two joints , usually the hip & / or knee, , 2, , , a stretching of a joint or joints stretching exercises with a slight movement of the other joints , 3, , , stretching two joints ,, 4,,, HL slight movement of all three joints , , 5, , , slight movement of two joints and a third joints stretching exercises , , 6, , , stretching two joints and slight movement of the third joint , 7 , all three joints of stretching exercises HL , , 8, , , no weight support paw foot wing song (Sweeping) or no weight support paw foot flat (Plantar,,,,,, placement),, 9,,, only in the standing posture ( that is, when at rest ) has to support the weight of the flat or occasionally , when </ entry> </ row> </ tbody> </ tgroup> </ table> </ tables> <tables TranNum="173" num="0002"> <table TranNum="174"> < tgroup TranNum = "175" cols = "1"> <colspec TranNum="176" colname="c001" colwidth="100%"/> <tbody TranNum="177"> <row TranNum="178"> <entry TranNum = "179" morerows = "1">,,,,, often or consistently support the weight of the back foot stride and non- stride , 10 , and occasionally support the weight of the foot ; non forelimb (FL) - HL coordination , 11, often to support the weight of consistent plantar stepping and non- FL-HL coordination , 12, often to support the weight of consistent plantar stepping and occasional FL-HL coordination , 13 , often to support consistent plantar stepping weight and often the FL-HL coordination , 14, when it is initially in contact with the surface , and just before the end of the standing posture of the foot from the ground or from time to time ,,,, , at the end when stepping , consistent weight supported plantar stepping , consistent FL-HL coordination and , ,,,, during the movement of the main paw position (pawposition) for the rotation ( inward or outward ) ; always If a ,,,, , the FL-HL coordination ; and occasional dorsal stepping , 15 , consistent plantar stepping and consistent FL-HL coordination ; and no forward movement during limb ,,,, , toe clearance (Toe, clearance) or occasional toe clearance ; major paw position and initial contact , ,,,, body parallel , 16, during a foot stepping gait and always consistent as one of the FL-HL coordination ; and body forward ,,,, , frequent toe clearance during exercise ; major paw position parallel to and at the time from initial contact , ,,,, earth rotation , and 17 , in consistently stepped foot during gait and consistent FL-HL coordination ; and body forward ,,,, , frequent toe clearance during exercise ; major paw position at initial contact and when the flat ground , ,,,, line , and 18 during the gait consistent plantar stepping and consistent FL-HL coordination ; and body forward ,,,, , consistent toe clearance occurs during exercise ; main the position of the feet flat during initial contact ,,,, , and from the ground when the line rotation , 19, during gait consistent plantar stepping and consistent FL-HL coordination ; and body forward , ,,,, consistently occurs during movement toe clearance ; major paw position at initial contact and leave, ,,,, while in parallel ; and tail down in some or all of the time , and 20 , consistent consistent plantar stepping and coordinated gait ; consistent toe clearance ; Lord, ,,,, paw position is parallel to the ground when the initial contact and ; and trunk instability ; tail always ,,, , , like a ground up , 21, consistent plantar stepping and consistent coordination of gait ; consistent toe clearance ; Lord, ,,,, paw position to standing posture for the entire period in parallel ; trunk stability consistent ; tail, ,,,, Department consistently upward </ entry> </ row> </ tbody> </ tgroup> </ table> </ tables> table 3.BBB movement rating scale
For these researchs of permanent damage, 36 rats with complete dura mater complete research analyzed.The animal of 11 (11) vacuum-therapy that begin one's study, due to urinary tract infection and renal failure, 1 animal was removed with 1 animal and removes 8 weeks the time in the time of 5 weeks.Therefore, the animal of 9 vacuum-therapy completes the research of 12 weeks.27 control animals start and complete research.The animal of vacuum-therapy presents larger functional rehabilitation rate (p<0.072) 3 weeks the time after damage: BBB scoring=12.818+/-1.401 (n=11) vacuum-therapy group is to 11.704+/-2.391 (n=27) matched group.The animal of vacuum-therapy presents significantly larger functional rehabilitation rate (p<0.001) 4 weeks the time after damage: BBB scoring=13.625+/-1.303 (n=11) vacuum-therapy group is to 11.500+/-0.707 matched group (n=27).Fig. 6 and 7.The recovery rate of vacuum-therapy animal is stable level, and the recovery level of control animals moves closer to the level of vacuum-therapy animal.Fig. 6 and 7.(note, studied 3 weeks of some animals (usually early stage in research), and the observed functional rehabilitation of some animals 12 weeks).
Except BBB estimates, adopt this is tested to method listed above, 2 sectional areas with the analyzed damage of animal MRI scanning front and rear spinal cord of complete dura mater change (for example, with mm
2mean) (scanning after the animal of vacuum-therapy is implemented to damage after treatment).In carrying out 4 animals of this analysis, only have the animal of 1 vacuum-therapy do not there is any technology or clash into error and can be used.In control animal, 1 has less height error, and its pin (release pin) of deviating from the contusion of spinal cord system closes when leave behind in foster place and occurs from it; All other control animals have significant shock error, and it hinders the analysis of spinal cord sectional area.The height that Machine Records falls the rat weight of vacuum-therapy is 24.8mm, and is 25.782mm for the height of control rats.
Forward Fig. 8 to, when scanning is carried out along spinal column (to afterbody), control animals shows that sectional area increases a little.To clashing into front scanning and clashing into rear scanning, both are apparent for this.More than damage, with the following position of damage, sectional area scans and clashes between rear scanning not remarkable different before shock.Before the above shock of damage, meansigma methods is 5.49mm
2+/-0.2 (n=5) is to clashing into rear meansigma methods 5.32mm
2+/-0.23 (n=4): p<0.211) (before the following shock of damage, meansigma methods is 6.81mm
2+/-0.25 (n=3) is to clashing into rear meansigma methods 6.46mm
2+/-0.78 (n=4): p<0.464).Yet, in impact site, significantly be greater than (p<0.001) shock starting section for sectional area after the control animals shock long-pending: clash into front area average 5.63mm
2+/-0.24 (n=5 scanning) is to area 6.43mm after average shock
2+/-0.32 (n=4 scanning).This most likely causes spinal cord swelling due to the restriction because of dura mater, because the bone that will become spinal cord diameter limiting factor is removed.
Do not resemble control animals, the animal of vacuum-therapy does not show that after vacuum-therapy the average diameter of damage location spinal cord increases, Fig. 9.Before the average shock of level of damage, area is 7.28mm
2+/-0.73 (n=4 scanning) is to area 7.03mm after average shock
2+/-0.99 (n=4 scanning) (p<0.73).The similarity of spinal cord size before damage location clashes into and after treatment is most likely owing to removing fluid in dura mater, so spinal cord keeps initial diameter.
Before the above area of damage clashes into, with scanning after treatment, be similar (there is no significant difference).Before shock, the above area of damage is that 7.79+/-0.64 (n=3 scanning) is to treating rear area 8.33+/-1.11 (n=5 scanning) (p<0.48).Below animal injury for vacuum-therapy, scan, after treatment, the sectional area of spinal cord significantly is greater than the sectional area before clashing into: clash into front area 7.61+/-0.43 (n=4 scanning) to treating rear area 10.76+/-0.35 (n=4 scanning), p<0.001.To the possible explanation that damages following spinal cord sectional area and increase, may be to be attributable to venous congestion.Perhaps, the vacuum applied may, automatically from the cerebrospinal fluid of spinal cord absorption on every side, make spinal cord expand to fill the canalis spinalis area in vertebral body.This expansion will play a part to make the dura mater internal pressure to reduce to minimum and contribute to the Cell protection vigor.
Those skilled in the art will be expressly understood these and other advantage of the present invention in above description.Therefore, those skilled in the art will appreciate that and can make and change or improve and do not deviate from extensive invention theory of the present invention embodiment described above.Therefore should be appreciated that and the invention is not restricted to specific embodiments described here, and be intended to comprise all changes and improvement, in the scope and spirit of the present invention that these changes and improvements are set forth in the claims.
Claims (17)
1. a device that is used for the treatment of the myeloid tissue of damage, it comprises:
But multiporous biological bond material, but this material has the pore structure that is shaped to allow gas communication between one or more holes of multiporous biological bond material and the myeloid tissue for the treatment of, but but the selected surface of multiporous biological bond material that the multiporous biological bond material is at least placed in the myeloid tissue of contiguous damage has enough little hole to prevent from being organized in wherein, grows; With
For generation of the vacuum source of negative pressure, but its in the mode with multiporous biological bond material gas communication to myeloid tissue's distribution negative pressure of being treated.
2. according to the device of claim 1, but wherein the multiporous biological bond material comprises out the chamber collagen protein.
3. according to the device of claim 1 or 2, but wherein the multiporous biological bond material comprises polyglycols citron acid esters.
4. according to the device of claim 1 or 2, but wherein the multiporous biological bond material comprises polyglycols citron acid esters and collagen protein.
5. according to the device of claim 1 or 2, but wherein the multiporous biological bond material comprises elastin laminin, hyaluronic acid, alginate or its combination.
6. according to the device of claim 1 or 2, but wherein the multiporous biological bond material comprises the electrospinning material.
7. according to the device of claim 1 or 2, but wherein the multiporous biological bond material comprises cast-molding material.
8. according to the device of claim 1 or 2, but wherein the multiporous biological bond material comprises printing material.
9. according to the device of claim 1 or 2 claim, but but the selected surface of multiporous biological bond material that wherein the multiporous biological bond material is at least placed in the myeloid tissue to contiguous damage has the pore size that is less than fibroblast and cord cell size.
10. according to the device of claim 1 or 2, but but wherein the multiporous biological bond material has the pore size that is greater than fibroblast and cord cell in the inside of biology bond material.
11. according to the device of claim 1 or 2, but but the position the selected surface of multiporous biological bond material that wherein the multiporous biological bond material is placed in the myeloid tissue except contiguous damage has the pore size that is greater than fibroblast and cord cell.
12. according to the device of claim 1 or 2 claim, but the protein motion that wherein pore size of multiporous biological bond material passes through even as big as allowing the large I of albumin.
13. according to the device of claim 1 or 2, but wherein the multiporous biological bond material comprises at least one sealed surface to prevent that negative pressure from therefrom transmitting.
14. according to the device of claim 1 or 2, but but the pore size that forms granulation tissue is impelled on the surface the surface of the selection that wherein the multiporous biological bond material comprises the multiporous biological bond material of placing even as big as the myeloid tissue except contiguous damage.
15., according to the device of claim 1 or 2, wherein vacuum source comprises vacuum pump.
16., according to the device of claim 1 or 2, its protective layer that comprises the myeloid tissue that is shaped to the covering damage is to keep negative pressure under the protective layer at the Spinal Cord tissue.
17., according to the device of claim 16, wherein protective layer comprises self attachment flaps.
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97888407P | 2007-10-10 | 2007-10-10 | |
US60/978,884 | 2007-10-10 | ||
US60/978884 | 2007-10-10 | ||
US8199708P | 2008-07-18 | 2008-07-18 | |
US61/081,997 | 2008-07-18 | ||
US61/081997 | 2008-07-18 | ||
US8855808P | 2008-08-13 | 2008-08-13 | |
US61/088558 | 2008-08-13 | ||
US61/088,558 | 2008-08-13 | ||
PCT/US2008/079364 WO2009049058A1 (en) | 2007-10-10 | 2008-10-09 | Devices and methods for treating spinal cord tissue |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101896140A CN101896140A (en) | 2010-11-24 |
CN101896140B true CN101896140B (en) | 2014-01-08 |
Family
ID=40549559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200880121075.8A Expired - Fee Related CN101896140B (en) | 2007-10-10 | 2008-10-09 | Devices and methods for treating spinal cord tissue |
Country Status (15)
Country | Link |
---|---|
US (4) | US8834520B2 (en) |
EP (1) | EP2205189B1 (en) |
JP (1) | JP5462175B2 (en) |
KR (1) | KR101600041B1 (en) |
CN (1) | CN101896140B (en) |
AU (1) | AU2008310819B2 (en) |
BR (1) | BRPI0817544A2 (en) |
CA (1) | CA2702239C (en) |
DK (1) | DK2205189T3 (en) |
ES (1) | ES2661762T3 (en) |
HK (1) | HK1150958A1 (en) |
IL (1) | IL204825A (en) |
RU (1) | RU2489993C2 (en) |
WO (1) | WO2009049058A1 (en) |
ZA (1) | ZA201002498B (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8377016B2 (en) | 2007-01-10 | 2013-02-19 | Wake Forest University Health Sciences | Apparatus and method for wound treatment employing periodic sub-atmospheric pressure |
BRPI0817544A2 (en) | 2007-10-10 | 2017-05-02 | Univ Wake Forest Health Sciences | apparatus for treating damaged spinal cord tissue |
CN102014980B (en) | 2008-01-09 | 2014-04-09 | 韦克福里斯特大学健康科学院 | Device and method for treating central nervous system pathology |
ES2633142T3 (en) | 2008-07-18 | 2017-09-19 | Wake Forest University Health Sciences | Apparatus for modulation of cardiac tissue through topical application of vacuum to minimize death and cell damage |
BRPI0914377A2 (en) | 2008-10-29 | 2019-09-24 | Kci Licensing Inc | '' Modular reduced pressure wound closure system for providing a closure force on a superficial wound, method of manufacturing a modular reduced pressure wound closure system for generating a closure force on a surface wound, method of surface wound treatment of patients, modular wound closure systems for wound closure in the patient epidermis using reduced pressure '' |
US9675358B2 (en) | 2012-04-12 | 2017-06-13 | Wake Forest University Health Sciences | Conduit for peripheral nerve replacement |
US9320840B2 (en) | 2012-10-05 | 2016-04-26 | Luis F. Angel | Catheter vacuum dressing apparatus and methods of use |
EP2911708A4 (en) | 2012-10-26 | 2016-06-22 | Univ Wake Forest Health Sciences | Novel nanofiber-based graft for heart valve replacement and methods of using the same |
WO2014110214A1 (en) * | 2013-01-10 | 2014-07-17 | The Cleveland Clinic Foundation | Deployable joint infection treatment system |
CN109730806B (en) | 2013-03-15 | 2023-01-24 | 伊瑟拉医疗公司 | Vascular treatment device and method |
CN108697423A (en) | 2016-02-16 | 2018-10-23 | 伊瑟拉医疗公司 | The part flow arrangement of suction unit and anchoring |
USD847864S1 (en) | 2018-01-22 | 2019-05-07 | Insera Therapeutics, Inc. | Pump |
WO2019173249A1 (en) * | 2018-03-05 | 2019-09-12 | William Loudon | Methods, materials, devices and systems for treating injuries to the central nervous system |
DE102018113580A1 (en) | 2018-06-07 | 2019-12-12 | Christoph Karl | METHOD AND DEVICE FOR PRODUCING AN IMPLANT |
Family Cites Families (507)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE561757C (en) | 1932-10-18 | Georg Heuchemer | Bell-shaped vaginal pessary | |
DE372727C (en) | 1923-03-31 | Ernst Moyat | Device for pneumatic suction and pressure massage | |
GB114754A (en) | 1918-04-18 | |||
GB190203090A (en) | 1902-02-07 | 1902-06-25 | William Hugh Alexander | Improvements in Shields for Protecting Corns, Bunions, or Vaccination Spots. |
US765746A (en) * | 1904-02-06 | 1904-07-26 | A D Gustin | Massage apparatus. |
US774529A (en) * | 1904-08-29 | 1904-11-08 | Charles C F Nieschang | Electrothermic and vacuum appliance. |
US843674A (en) * | 1906-06-20 | 1907-02-12 | Edgar M Funk | Massaging apparatus. |
US1000001A (en) | 1908-11-09 | 1911-08-08 | Robert A C Holz | Vacuum apparatus for hyperemic treatments. |
US1007631A (en) | 1909-02-16 | 1911-10-31 | John Calvin Bascue | Stalk-cutter. |
FR500253A (en) | 1919-05-30 | 1920-03-06 | Maurice Leger | Suction cup device |
US1385346A (en) * | 1919-06-27 | 1921-07-19 | Taylor Walter Herbert | Surgical wound-dam |
US1355846A (en) * | 1920-02-06 | 1920-10-19 | David A Rannells | Medical appliance |
US1355679A (en) * | 1920-04-28 | 1920-10-12 | Mcconnell Thomas | Vacuum apparatus |
SE84485C1 (en) | 1931-04-08 | 1935-10-01 | ||
US1936129A (en) * | 1931-12-01 | 1933-11-21 | Andrew J Fisk | Method of treating the skin and device therefor |
US2025492A (en) | 1934-11-09 | 1935-12-24 | Aird Andrew | Wound drainage device |
US2232254A (en) * | 1936-05-26 | 1941-02-18 | Samuel Schadel | Massage device |
US2122121A (en) | 1937-02-02 | 1938-06-28 | Tillotson Joseph Elmer | Surgical aspirated drainage cup |
US2221758A (en) | 1937-05-12 | 1940-11-19 | Elmquist Francis | Surgical dressing |
US2195771A (en) * | 1937-11-09 | 1940-04-02 | Estler Louis Edmond | Surgical suction drainage cup |
US2338339A (en) * | 1940-11-08 | 1944-01-04 | Mere | Massaging vibrator |
US2280915A (en) * | 1941-04-03 | 1942-04-28 | John H Johnson | Device for irrigating and treating wounds |
US2443481A (en) | 1942-10-19 | 1948-06-15 | Sene Leon Paul | Device for the treatment of wounds and the like lesions |
DK64055C (en) | 1943-02-22 | 1945-10-29 | Joergen Adolph Smith | Bell for the Treatment of Muscles and Other Deeper Tissues in the Human or Animal Body. |
DE847475C (en) | 1944-08-22 | 1952-08-25 | Heinrich C Ulrich | Device for draining wounds |
US2573791A (en) | 1947-04-19 | 1951-11-06 | John N M Howells | Heat applying bandage |
GB641061A (en) | 1947-09-06 | 1950-08-02 | James Donald Maclaurin | Improvements in method of treating wounds |
US2577945A (en) | 1947-12-06 | 1951-12-11 | Atherton Harold Starr | Plaster or bandage for skin application |
US2547758A (en) * | 1949-01-05 | 1951-04-03 | Wilmer B Keeling | Instrument for treating the male urethra |
US2632443A (en) | 1949-04-18 | 1953-03-24 | Eleanor P Lesher | Surgical dressing |
CH296748A (en) | 1951-04-12 | 1954-02-28 | Ciba Geigy | Process for the production of a body with a rotationally symmetrical cavity from a synthetic resin mass which can be hardened by means of heat and hollow bodies obtained by the process. |
US2682873A (en) | 1952-07-30 | 1954-07-06 | Johnson & Johnson | General purpose protective dressing |
NL189176B (en) | 1956-07-13 | 1900-01-01 | Hisamitsu Pharmaceutical Co | PLASTER BASED ON A SYNTHETIC RUBBER. |
US2969057A (en) * | 1957-11-04 | 1961-01-24 | Brady Co W H | Nematodic swab |
US3026874A (en) * | 1959-11-06 | 1962-03-27 | Robert C Stevens | Wound shield |
US3042041A (en) * | 1960-03-09 | 1962-07-03 | Mario E Jascalevich | Device for draining wounds |
US3115138A (en) | 1960-07-14 | 1963-12-24 | Mcelvenny | Evacuator |
FR1303238A (en) | 1961-09-07 | 1962-09-07 | Pad | |
US3315665A (en) | 1963-10-11 | 1967-04-25 | Norman A Macleod | Method and apparatus for therapy of skin tissue |
US3324855A (en) * | 1965-01-12 | 1967-06-13 | Henry J Heimlich | Surgical sponge stick |
US3382867A (en) * | 1965-03-22 | 1968-05-14 | Ruby L. Reaves | Body portion developing device with combined vacuum and vibrating means |
US3367332A (en) * | 1965-08-27 | 1968-02-06 | Gen Electric | Product and process for establishing a sterile area of skin |
US3429313A (en) | 1966-02-01 | 1969-02-25 | Ram Domestic Products Co | Medical drainage pump |
US3520300A (en) * | 1967-03-15 | 1970-07-14 | Amp Inc | Surgical sponge and suction device |
US3528416A (en) | 1967-11-06 | 1970-09-15 | Lawrence J Chamberlain | Protective bandage |
US3486504A (en) | 1967-11-20 | 1969-12-30 | Lawthan M Austin Jr | Device for applying dressing,medication and suction |
US3572340A (en) * | 1968-01-11 | 1971-03-23 | Kendall & Co | Suction drainage device |
GB1273342A (en) | 1968-01-31 | 1972-05-10 | Nat Res Dev | Improvements relating to fluid mattresses |
NO134790C (en) | 1968-07-09 | 1984-03-22 | Smith & Nephew | Kleber ,; PRESSURE SENSITIVE, WATERPUME-PERMEABLE PRODUCT FOR SKIN USE BY HUMANS. |
US3568675A (en) * | 1968-08-30 | 1971-03-09 | Clyde B Harvey | Fistula and penetrating wound dressing |
DE1963258C3 (en) | 1969-12-17 | 1974-09-05 | Atmos Fritzsching & Co, Gmbh, 7825 Lenzkirch | Drainage device |
US3610238A (en) * | 1970-04-28 | 1971-10-05 | Us Health Education & Welfare | Wound infection prevention device |
US3682180A (en) * | 1970-06-08 | 1972-08-08 | Coilform Co Inc | Drain clip for surgical drain |
BE789293Q (en) | 1970-12-07 | 1973-01-15 | Parke Davis & Co | MEDICO-SURGICAL DRESSING FOR BURNS AND SIMILAR LESIONS |
US3713622A (en) * | 1971-02-26 | 1973-01-30 | Amp Inc | Closure device for flexible tubing |
US3753439A (en) * | 1971-08-24 | 1973-08-21 | Elias & Brugarolas | General purpose surgical drain |
US3782377A (en) | 1971-09-07 | 1974-01-01 | Illinois Tool Works | Sterile plastic shield |
BE789739A (en) | 1971-10-05 | 1973-04-05 | Lock Peter M | SURGICAL DRESSING |
US3938540A (en) * | 1971-10-07 | 1976-02-17 | Medical Development Corporation | Vacuum-operated fluid bottle for tandem systems |
US3782387A (en) | 1972-02-29 | 1974-01-01 | R Falabella | Apparatus and methods for obtaining and making skin grafts |
US3814095A (en) | 1972-03-24 | 1974-06-04 | H Lubens | Occlusively applied anesthetic patch |
US3812972A (en) | 1972-05-02 | 1974-05-28 | J Rosenblum | Liquid filter and method for fabricating same |
US3874387A (en) * | 1972-07-05 | 1975-04-01 | Pasquale P Barbieri | Valved hemostatic pressure cap |
JPS5238680B2 (en) * | 1972-12-27 | 1977-09-30 | ||
US3826254A (en) * | 1973-02-26 | 1974-07-30 | Verco Ind | Needle or catheter retaining appliance |
US3954105A (en) * | 1973-10-01 | 1976-05-04 | Hollister Incorporated | Drainage system for incisions or wounds in the body of an animal |
CA1031647A (en) | 1973-10-01 | 1978-05-23 | Hollister Incorporated | Drainage system for incisions or wounds in the body of an animal |
US3992725A (en) | 1973-11-16 | 1976-11-23 | Homsy Charles A | Implantable material and appliances and method of stabilizing body implants |
US3908664A (en) * | 1974-03-01 | 1975-09-30 | Herbert S Loseff | Wound suction tube and retrograde flushing |
US3993080A (en) * | 1974-03-01 | 1976-11-23 | Loseff Herbert S | Suction tube and retrograde flushing for wounds, body cavities and the like |
US3903882A (en) | 1974-04-19 | 1975-09-09 | American Cyanamid Co | Composite dressing |
US3935863A (en) | 1974-07-19 | 1976-02-03 | Kliger Herbert L | Surgical sponge |
US3998227A (en) | 1974-09-13 | 1976-12-21 | Medical Development Corporation | Regulator structure and system |
US3978855A (en) | 1975-01-17 | 1976-09-07 | Ionics Lyo Products Company | Polyurethane foam surgical dressing |
USRE29319E (en) * | 1975-04-07 | 1977-07-26 | Hollister Incorporated | Drainage system for incisions or wounds in the body of an animal |
US4191204A (en) | 1975-04-14 | 1980-03-04 | International Paper Company | Pressure responsive fluid collection system |
US4058123A (en) * | 1975-10-01 | 1977-11-15 | International Paper Company | Combined irrigator and evacuator for closed wounds |
SU587941A1 (en) | 1976-06-01 | 1978-01-15 | Предприятие П/Я А-3959 | Device for cleansing infected wounds and cavities |
US4187852A (en) | 1976-07-09 | 1980-02-12 | The University Of Alabama | Synthetic elastomeric insoluble cross-linked polypentapeptide |
US4080970A (en) * | 1976-11-17 | 1978-03-28 | Miller Thomas J | Post-operative combination dressing and internal drain tube with external shield and tube connector |
US4139004A (en) * | 1977-02-17 | 1979-02-13 | Gonzalez Jr Harry | Bandage apparatus for treating burns |
GB1549756A (en) | 1977-03-10 | 1979-08-08 | Everett W | Wound irrigating device |
US4184510A (en) | 1977-03-15 | 1980-01-22 | Fibra-Sonics, Inc. | Valued device for controlling vacuum in surgery |
US4156066A (en) | 1977-06-23 | 1979-05-22 | Tyndale Plains - Hunter Ltd. | Polyurethane polymers characterized by lactone groups and hydroxyl groups in the polymer backbone |
US4149541A (en) * | 1977-10-06 | 1979-04-17 | Moore-Perk Corporation | Fluid circulating pad |
CH623546A5 (en) * | 1977-11-09 | 1981-06-15 | Schweiter Ag Maschf | |
US4256109A (en) | 1978-07-10 | 1981-03-17 | Nichols Robert L | Shut off valve for medical suction apparatus |
US4224945A (en) * | 1978-08-30 | 1980-09-30 | Jonathan Cohen | Inflatable expansible surgical pressure dressing |
US4224941A (en) * | 1978-11-15 | 1980-09-30 | Stivala Oscar G | Hyperbaric treatment apparatus |
SE414994B (en) * | 1978-11-28 | 1980-09-01 | Landstingens Inkopscentral | VENKATETERFORBAND |
GB2047543B (en) * | 1978-12-06 | 1983-04-20 | Svedman Paul | Device for treating tissues for example skin |
US4250882A (en) * | 1979-01-26 | 1981-02-17 | Medical Dynamics, Inc. | Wound drainage device |
US4221215A (en) | 1979-04-19 | 1980-09-09 | Isidore Mandelbaum | Anchoring and occluding surgical dressing |
US4261363A (en) * | 1979-11-09 | 1981-04-14 | C. R. Bard, Inc. | Retention clips for body fluid drains |
ATE14835T1 (en) * | 1980-03-11 | 1985-08-15 | Schmid Eduard | SKIN GRAFT PRESSURE BANDAGE. |
US4399816A (en) | 1980-03-17 | 1983-08-23 | Spangler George M | Wound protector with transparent cover |
US5445604A (en) | 1980-05-22 | 1995-08-29 | Smith & Nephew Associated Companies, Ltd. | Wound dressing with conformable elastomeric wound contact layer |
US4297995A (en) * | 1980-06-03 | 1981-11-03 | Key Pharmaceuticals, Inc. | Bandage containing attachment post |
IE51473B1 (en) * | 1980-08-13 | 1986-12-24 | Smith & Nephew Ass | Polymer blend films,their preparation and use |
US4341209A (en) | 1981-01-12 | 1982-07-27 | The Kendall Company | Adhesive bandage with foam backing |
DE3102674A1 (en) | 1981-01-28 | 1982-09-02 | Walter Dr.-Ing. 5100 Aachen Jürgens | Bandaging material |
US4753231A (en) * | 1981-02-13 | 1988-06-28 | Smith & Nephew Associated Companies P.L.C. | Adhesive wound dressing |
NZ199684A (en) | 1981-02-13 | 1985-03-20 | Smith & Nephew Ass | Wound dressing;wound facing layer a conformable elastomeric integral net |
US4860737A (en) | 1981-02-13 | 1989-08-29 | Smith And Nephew Associated Companies P.L.C. | Wound dressing, manufacture and use |
US4465485A (en) | 1981-03-06 | 1984-08-14 | Becton, Dickinson And Company | Suction canister with unitary shut-off valve and filter features |
US4392853A (en) * | 1981-03-16 | 1983-07-12 | Rudolph Muto | Sterile assembly for protecting and fastening an indwelling device |
US4457755A (en) | 1981-04-02 | 1984-07-03 | Wilson John D | Surgical `in-line` evacuator |
US4373519A (en) * | 1981-06-26 | 1983-02-15 | Minnesota Mining And Manufacturing Company | Composite wound dressing |
US4419097A (en) | 1981-07-31 | 1983-12-06 | Rexar Industries, Inc. | Attachment for catheter tube |
US4459139A (en) * | 1981-09-14 | 1984-07-10 | Gelman Sciences Inc. | Disposable filter device and liquid aspirating system incorporating same |
SE429197B (en) * | 1981-10-14 | 1983-08-22 | Frese Nielsen | SAR TREATMENT DEVICE |
DE3146266A1 (en) * | 1981-11-21 | 1983-06-01 | B. Braun Melsungen Ag, 3508 Melsungen | COMBINED DEVICE FOR A MEDICAL SUCTION DRAINAGE |
US4499896A (en) | 1982-03-30 | 1985-02-19 | Minnesota Mining And Manufacturing Co. | Reservoir wound dressing |
US4475909A (en) * | 1982-05-06 | 1984-10-09 | Eisenberg Melvin I | Male urinary device and method for applying the device |
US4465062A (en) * | 1982-05-14 | 1984-08-14 | Gina Versaggi | Noninvasive seal for a sucking chest wound |
NL8202893A (en) | 1982-07-16 | 1984-02-16 | Rijksuniversiteit | ORGANIC Tolerant, ANTHITHROMBOGENIC MATERIAL, SUITABLE FOR RECOVERY SURGERY. |
US4569674A (en) * | 1982-08-03 | 1986-02-11 | Stryker Corporation | Continuous vacuum wound drainage system |
IT211654Z2 (en) * | 1985-07-17 | 1989-04-07 | Abbate Mariarosa | VARIABLE DEPRESSION TREATMENT APPARATUS FOR LOCATION, AMPLITUDE AND FREQUENCY WITH ELECTRONIC COMMAND AND CONTROL. |
NZ206837A (en) | 1983-01-27 | 1986-08-08 | Johnson & Johnson Prod Inc | Thin film adhesive dressing:backing material in three sections |
US4533352A (en) | 1983-03-07 | 1985-08-06 | Pmt Inc. | Microsurgical flexible suction mat |
SU1251912A1 (en) | 1983-04-27 | 1986-08-23 | Горьковский государственный медицинский институт им.С.М.Кирова | Method of treatment of unformed fistula |
DE3321151C2 (en) * | 1983-06-11 | 1986-09-18 | Walter Küsnacht Beck | Device for aspirating secretions |
US4540412A (en) * | 1983-07-14 | 1985-09-10 | The Kendall Company | Device for moist heat therapy |
US4778446A (en) | 1983-07-14 | 1988-10-18 | Squibb & Sons Inc | Wound irrigation and/or drainage device |
US4624656A (en) * | 1983-07-25 | 1986-11-25 | Hospitak, Inc. | Hyperbaric gas treatment device |
US4553967A (en) | 1983-10-14 | 1985-11-19 | E. R. Squibb & Sons, Inc. | Wound care and drainage system having hand access port |
US4543100A (en) * | 1983-11-01 | 1985-09-24 | Brodsky Stuart A | Catheter and drain tube retainer |
US4579555A (en) | 1983-12-05 | 1986-04-01 | Sil-Fab Corporation | Surgical gravity drain having aligned longitudinally extending capillary drainage channels |
US4573965A (en) * | 1984-02-13 | 1986-03-04 | Superior Plastic Products Corp. | Device for draining wounds |
SU1268175A1 (en) | 1984-03-27 | 1986-11-07 | Deneka Evgenij R | Apparatus for vacuum-massage |
US4837285A (en) * | 1984-03-27 | 1989-06-06 | Medimatrix | Collagen matrix beads for soft tissue repair |
GB2157958A (en) | 1984-05-03 | 1985-11-06 | Ernest Edward Austen Bedding | Ball game net support |
US4897081A (en) | 1984-05-25 | 1990-01-30 | Thermedics Inc. | Percutaneous access device |
GB8419745D0 (en) | 1984-08-02 | 1984-09-05 | Smith & Nephew Ass | Wound dressing |
US4872450A (en) | 1984-08-17 | 1989-10-10 | Austad Eric D | Wound dressing and method of forming same |
US4679590A (en) | 1984-08-31 | 1987-07-14 | Hergenroeder Patrick T | Receptacle for collecting fluids |
US4627427A (en) | 1984-10-17 | 1986-12-09 | Minnesota Mining And Manufacturing Company | Universal medical cover sheet and process for draping |
US4655754A (en) * | 1984-11-09 | 1987-04-07 | Stryker Corporation | Vacuum wound drainage system and lipids baffle therefor |
DE3441893A1 (en) | 1984-11-16 | 1986-05-28 | Walter Küsnacht Beck | METHOD AND DEVICE FOR SUCTIONING SECRETARY LIQUID FROM A Wound |
US4605399A (en) * | 1984-12-04 | 1986-08-12 | Complex, Inc. | Transdermal infusion device |
US4773409A (en) | 1985-09-20 | 1988-09-27 | E. R. Squibb & Sons, Inc. | Wound dressing |
US4664652A (en) | 1985-02-07 | 1987-05-12 | Snyder Laboratories, Inc. | Wound evacuator |
US4717382A (en) * | 1985-04-18 | 1988-01-05 | Emergency Management Products, Inc. | Noninvasive apparatus for treating a sucking chest wound |
JPH0648860Y2 (en) | 1985-05-29 | 1994-12-12 | 沖電気工業株式会社 | Jig for semiconductor wafer |
US4637819A (en) | 1985-05-31 | 1987-01-20 | The Procter & Gamble Company | Macroscopically expanded three-dimensional polymeric web for transmitting both dynamically deposited and statically contacted fluids from one surface to the other |
GB2176402B (en) | 1985-06-20 | 1989-04-19 | Craig Med Prod Ltd | Wound management appliance for use on the human skin |
EP0228466B1 (en) | 1985-07-16 | 1995-08-30 | General Polymeric Corporation | Fluid-flow controlling device and apparatus employing same |
SU1416108A1 (en) | 1985-07-24 | 1988-08-15 | Харьковский Научно-Исследовательский Институт Ортопедии И Травматологии Им.Проф.М.И.Ситенко | Method of curing open wounds |
US4640688A (en) * | 1985-08-23 | 1987-02-03 | Mentor Corporation | Urine collection catheter |
US4710165A (en) | 1985-09-16 | 1987-12-01 | Mcneil Charles B | Wearable, variable rate suction/collection device |
US4633863A (en) | 1985-09-27 | 1987-01-06 | Filips Chester P | Arterial anchor bandage |
DE3539533A1 (en) | 1985-11-07 | 1987-05-14 | Liedtke Pharmed Gmbh | Plastic plaster |
US4733659A (en) | 1986-01-17 | 1988-03-29 | Seton Company | Foam bandage |
WO1987004626A1 (en) | 1986-01-31 | 1987-08-13 | Osmond, Roger, L., W. | Suction system for wound and gastro-intestinal drainage |
US4838883A (en) * | 1986-03-07 | 1989-06-13 | Nissho Corporation | Urine-collecting device |
US4875473A (en) | 1986-04-03 | 1989-10-24 | Bioderm, Inc. | Multi-layer wound dressing having oxygen permeable and oxygen impermeable layers |
US4667666A (en) | 1986-04-18 | 1987-05-26 | Alice Fryslie | Protective bandaging device |
CH670049A5 (en) * | 1986-04-24 | 1989-05-12 | Vebo | |
US4641643A (en) | 1986-04-28 | 1987-02-10 | Greer Leland H | Resealing skin bandage |
JPS62281965A (en) * | 1986-05-29 | 1987-12-07 | テルモ株式会社 | Catheter and catheter fixing member |
GB8620227D0 (en) | 1986-08-20 | 1986-10-01 | Smith & Nephew Ass | Wound dressing |
GB8621884D0 (en) * | 1986-09-11 | 1986-10-15 | Bard Ltd | Catheter applicator |
GB2195255B (en) | 1986-09-30 | 1991-05-01 | Vacutec Uk Limited | Apparatus for vacuum treatment of an epidermal surface |
US4743232A (en) * | 1986-10-06 | 1988-05-10 | The Clinipad Corporation | Package assembly for plastic film bandage |
DE3634569A1 (en) * | 1986-10-10 | 1988-04-21 | Sachse Hans E | CONDOM CATHETER, A URINE TUBE CATHETER FOR PREVENTING RISING INFECTIONS |
DE3751254D1 (en) | 1986-10-31 | 1995-05-24 | Nippon Zeon Co | Wound dressing. |
US5736372A (en) | 1986-11-20 | 1998-04-07 | Massachusetts Institute Of Technology | Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure |
JPS63135179A (en) * | 1986-11-26 | 1988-06-07 | 立花 俊郎 | Subcataneous drug administration set |
US4759354A (en) * | 1986-11-26 | 1988-07-26 | The Kendall Company | Wound dressing |
US4820265A (en) * | 1986-12-16 | 1989-04-11 | Minnesota Mining And Manufacturing Company | Tubing set |
DE3644588C1 (en) | 1986-12-27 | 1988-03-10 | Ethicon Gmbh | Implant and process for its manufacture |
US4764167A (en) * | 1987-01-14 | 1988-08-16 | Tu Ho C | Safety newborn mucous suction device |
WO1988005319A1 (en) | 1987-01-20 | 1988-07-28 | Medinorm Aktiengesellschaft Medizintechnische Prod | Wound fluid aspirating device |
JP2935708B2 (en) | 1987-02-20 | 1999-08-16 | ドレナート,クラウス | Bone screw |
GB8706116D0 (en) * | 1987-03-14 | 1987-04-15 | Smith & Nephew Ass | Adhesive dressings |
US4778456A (en) * | 1987-04-03 | 1988-10-18 | Oddvin Lokken | Method of sterilizing an operating field and sterilized cassette therefor |
US4747166A (en) | 1987-05-15 | 1988-05-31 | Kuntz David H | Fluid aspiration system for the management of urinary incontinence |
US4931519A (en) * | 1987-06-02 | 1990-06-05 | Warner-Lambert Company | Copolymers from n-alkyl-3-alkenylene-2-pyrrolidone |
US5035884A (en) * | 1987-06-02 | 1991-07-30 | Warner-Lambert Company | Methylene pyrrolidone copolymers for contact lens and pharmaceutical preparations |
US4851545A (en) * | 1987-06-02 | 1989-07-25 | Warner-Lambert Company | N-substituted-3-alkylene-2-pyrrolidone compounds |
CA1313987C (en) | 1987-06-22 | 1993-03-02 | Toshio Izumi | Suction equipment for medical operation |
JPH0788433B2 (en) | 1987-06-26 | 1995-09-27 | ニッピコラ−ゲン工業株式会社 | Collagen sponge |
US4863449A (en) * | 1987-07-06 | 1989-09-05 | Hollister Incorporated | Adhesive-lined elastic condom cathether |
US5002529A (en) | 1987-07-10 | 1991-03-26 | Solco Basle, Inc. | Postoperative wound drainage |
FI77569C (en) * | 1987-07-13 | 1989-04-10 | Huhtamaeki Oy | ANORDINATION FOR THE PURPOSE OF THE OPERATIONS AND THE OPERATIONS OF ELLER EN VAEVNAD. |
FR2618337B1 (en) | 1987-07-22 | 1989-12-15 | Dow Corning Sa | SURGICAL DRESSING AND PROCESS FOR MAKING SAME |
US4822278A (en) | 1987-10-16 | 1989-04-18 | The Wilkinson Dental Manufacturing Company, Inc. | Dental veneer instrument |
IT8748594A0 (en) | 1987-11-09 | 1987-11-09 | Checconi Pietro E Matteucci Do | DRESSING PATCH WITH BUILT-IN SPACER |
US5176663A (en) | 1987-12-02 | 1993-01-05 | Pal Svedman | Dressing having pad with compressibility limiting elements |
US4834110A (en) * | 1988-02-01 | 1989-05-30 | Richard Patricia A | Suction clamped treatment cup saliva sampler |
US4906240A (en) | 1988-02-01 | 1990-03-06 | Matrix Medica, Inc. | Adhesive-faced porous absorbent sheet and method of making same |
US4921492A (en) * | 1988-05-31 | 1990-05-01 | Laser Technologies Group, Inc. | End effector for surgical plume evacuator |
US4925447A (en) * | 1988-06-22 | 1990-05-15 | Rosenblatt/Ima Invention Enterprises | Aspirator without partition wall for collection of bodily fluids including improved safety and efficiency elements |
US4950483A (en) | 1988-06-30 | 1990-08-21 | Collagen Corporation | Collagen wound healing matrices and process for their production |
US5024841A (en) | 1988-06-30 | 1991-06-18 | Collagen Corporation | Collagen wound healing matrices and process for their production |
US4917112A (en) * | 1988-08-22 | 1990-04-17 | Kalt Medical Corp. | Universal bandage with transparent dressing |
US5003971A (en) | 1988-09-02 | 1991-04-02 | Buckley John T | Expansion system for a medical and surgical dressing |
US5215539A (en) | 1988-10-12 | 1993-06-01 | Schoolman Scientific Corporation | Vacuum strip apparatus for surgery |
GB8906100D0 (en) | 1989-03-16 | 1989-04-26 | Smith & Nephew | Laminates |
US4969880A (en) * | 1989-04-03 | 1990-11-13 | Zamierowski David S | Wound dressing and treatment method |
US5527293A (en) | 1989-04-03 | 1996-06-18 | Kinetic Concepts, Inc. | Fastening system and method |
US5261893A (en) | 1989-04-03 | 1993-11-16 | Zamierowski David S | Fastening system and method |
US5100396A (en) * | 1989-04-03 | 1992-03-31 | Zamierowski David S | Fluidic connection system and method |
US5106362A (en) * | 1989-04-13 | 1992-04-21 | The Kendall Company | Vented absorbent dressing |
US5086764A (en) * | 1989-04-13 | 1992-02-11 | Thomas Gilman | Absorbent dressing |
US5358494A (en) | 1989-07-11 | 1994-10-25 | Svedman Paul | Irrigation dressing |
JP2719671B2 (en) | 1989-07-11 | 1998-02-25 | 日本ゼオン株式会社 | Wound dressing |
SE462516B (en) | 1989-07-11 | 1990-07-09 | Paal Svedman | WOOL TAPE FOR DEEP SAAR |
US5042978A (en) | 1989-08-08 | 1991-08-27 | Eastman Kodak Company | Container using a mass of porous material for liquid retention |
JPH0336640U (en) | 1989-08-23 | 1991-04-10 | ||
US5019086A (en) | 1989-09-12 | 1991-05-28 | Neward Theodore C | Manipulable vacuum extractor for childbirth and method of using the same |
US4988336A (en) | 1989-09-22 | 1991-01-29 | Allied Healthcare Products, Inc. | Electronic suction regulator |
US5106629A (en) | 1989-10-20 | 1992-04-21 | Ndm Acquisition Corp. | Transparent hydrogel wound dressing |
DE4111122A1 (en) | 1989-10-27 | 1993-04-29 | Wolfgang Dr Neher | Equipment for cleansing and therapeutic treatment of wounds - has rubber sleeves or bell shaped covers to seal treatment area with pumped circulation and cleaning of fluid media in closed circuit |
US4969881A (en) * | 1989-11-06 | 1990-11-13 | Connecticut Artcraft Corp. | Disposable hyperbaric oxygen dressing |
US5071403A (en) | 1989-11-14 | 1991-12-10 | Isg/Ag | Method and apparatus for protecting the pump of a breast pump from fouling by milk |
US5014389A (en) | 1989-11-15 | 1991-05-14 | Concept Inc. | Foot manipulated suction head and method for employing same |
US5152757A (en) | 1989-12-14 | 1992-10-06 | Brigham And Women's Hospital | System for diagnosis and treatment of wounds |
US5002528A (en) | 1989-12-15 | 1991-03-26 | Aubrey Palestrant | Percutaneous irrigation and drainage system |
NL9000356A (en) | 1990-02-14 | 1991-09-02 | Cordis Europ | DRAINAGE CATHETER. |
US5228431A (en) | 1990-04-26 | 1993-07-20 | Giarretto Ralph R | Drug-free method for treatment of the scalp for therapeutic purposes |
SE470347B (en) | 1990-05-10 | 1994-01-31 | Pharmacia Lkb Biotech | Microstructure for fluid flow systems and process for manufacturing such a system |
US5060662A (en) | 1990-07-06 | 1991-10-29 | Farnswoth Iii Kenneth F | Open air bandage |
US5086763A (en) | 1990-08-06 | 1992-02-11 | Hathman Johnnie L | Protective reclosable wound dressing |
US5135518A (en) | 1990-08-28 | 1992-08-04 | Barbara Vera | Heat-retentive wet compress |
US5451215A (en) | 1990-09-17 | 1995-09-19 | Wolter; Dietmar | Suction drain for the aspiration of discharges |
EP0485657A1 (en) | 1990-11-15 | 1992-05-20 | Catalina Biomedical Corporation | Modifiable, semi permeable wound dressing |
DE4037931A1 (en) | 1990-11-23 | 1992-05-27 | Detlef Dr Ing Behrend | Swab for resorbable protection of wound cavity - with soft foam body in soft foam casing with embedded resorbable hollow fibres connected to tube |
US5697920A (en) | 1991-01-18 | 1997-12-16 | Gibbons; De Lamar | Body vacuum |
AU1239692A (en) | 1991-01-18 | 1992-08-27 | Delamar Gibbons | Body vacuum |
US5160322A (en) | 1991-02-28 | 1992-11-03 | Brunswick Biomedical Technologies, Inc. | Occlusive chest sealing valve |
US5419768A (en) | 1991-03-07 | 1995-05-30 | Aeros Instruments, Inc. | Electrical medical vacuum regulator |
US5199443A (en) | 1991-03-26 | 1993-04-06 | Empi, Inc. | Incontinence electrode apparatus |
US5149331A (en) | 1991-05-03 | 1992-09-22 | Ariel Ferdman | Method and device for wound closure |
US5230350A (en) | 1991-05-29 | 1993-07-27 | Tabex Industries, Inc. | Moisture barrier for indwelling catheters and the like |
GB9113448D0 (en) | 1991-06-21 | 1991-08-07 | Smith & Nephew | Adhesive compositions and products |
US5263922A (en) | 1991-08-26 | 1993-11-23 | Plasco, Inc. | Valved bandage |
US5224947A (en) | 1991-10-21 | 1993-07-06 | Cooper Richard N | Soft, readily expandable vacuum bell assembly |
US7198046B1 (en) | 1991-11-14 | 2007-04-03 | Wake Forest University Health Sciences | Wound treatment employing reduced pressure |
US5645081A (en) * | 1991-11-14 | 1997-07-08 | Wake Forest University | Method of treating tissue damage and apparatus for same |
US5636643A (en) | 1991-11-14 | 1997-06-10 | Wake Forest University | Wound treatment employing reduced pressure |
US5170781A (en) | 1991-11-15 | 1992-12-15 | Loomis Dawn L | Protective bandage having improved impact protection |
CA2070590C (en) | 1991-12-16 | 2002-10-01 | Kimberly-Clark Worldwide, Inc. | Surgical fluid evacuation system |
EP0670704B1 (en) | 1992-01-17 | 1999-09-22 | Dobloug Talbot, Anette | A heat conserving bandage |
US5431662A (en) | 1992-02-12 | 1995-07-11 | United States Surgical Corporation | Manipulator apparatus |
US5484399A (en) | 1992-02-27 | 1996-01-16 | Sloan-Kettering Institute For Cancer Research | Process and device to reduce interstitial fluid pressure in tissue |
US5167613A (en) | 1992-03-23 | 1992-12-01 | The Kendall Company | Composite vented wound dressing |
DK168420B1 (en) | 1992-03-27 | 1994-03-28 | Coloplast As | A heat dressing |
US5176667A (en) | 1992-04-27 | 1993-01-05 | Debring Donald L | Liquid collection apparatus |
CA2137275A1 (en) | 1992-06-03 | 1993-12-09 | Richard L. Eckert | Bandage for continuous application of biologicals |
CA2138402C (en) | 1992-06-19 | 2004-01-27 | Scott D. Augustine | Wound covering |
US5954680A (en) | 1992-06-19 | 1999-09-21 | Augustine Medical, Inc. | Near hyperthermic heater wound covering |
US5947914A (en) | 1995-02-21 | 1999-09-07 | Augustine Medical, Inc. | Wound covering |
US5986163A (en) | 1992-06-19 | 1999-11-16 | Augustine Medical, Inc. | Normothermic heater wound covering |
US5964723A (en) | 1992-06-19 | 1999-10-12 | Augustine Medical, Inc. | Normothermic tissue heating wound covering |
DE4221006C2 (en) | 1992-06-26 | 1994-06-30 | S & G Implants Gmbh | Implant to replace a back patella part |
US5678564A (en) | 1992-08-07 | 1997-10-21 | Bristol Myers Squibb | Liquid removal system |
US5354268A (en) | 1992-11-04 | 1994-10-11 | Medical Instrument Development Laboratories, Inc. | Methods and apparatus for control of vacuum and pressure for surgical procedures |
DE4310968C2 (en) | 1993-04-03 | 1995-08-10 | Kubein Meesenburg Dietmar | Artificial joint as an endoprosthesis for the human patella joint |
US5645537A (en) * | 1993-04-20 | 1997-07-08 | Advanced Cytometrix, Inc. | Aspiration needle and syringe for use therewith, apparatus incorporating the same and kit for use in fine needle aspiration cytology, and method |
US5330452A (en) | 1993-06-01 | 1994-07-19 | Zook Gerald P | Topical medicating device |
US5478333A (en) | 1994-03-04 | 1995-12-26 | Asherman, Jr.; Richard E. | Medical dressing for treating open chest injuries |
US5344415A (en) | 1993-06-15 | 1994-09-06 | Deroyal Industries, Inc. | Sterile system for dressing vascular access site |
ES2198419T3 (en) | 1993-07-08 | 2004-02-01 | Aircast, Inc. | APPLIANCE TO PROVIDE INTERMITTENT THERAPEUTIC COMPRESSION TO REDUCE THE RISK OF DVT. |
US5607590A (en) | 1993-08-06 | 1997-03-04 | Shimizu; Yasuhiko | Material for medical use and process for preparing same |
AU7676894A (en) | 1993-08-27 | 1995-03-21 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Convection-enhanced drug delivery |
US5437651A (en) | 1993-09-01 | 1995-08-01 | Research Medical, Inc. | Medical suction apparatus |
US5490962A (en) | 1993-10-18 | 1996-02-13 | Massachusetts Institute Of Technology | Preparation of medical devices by solid free-form fabrication methods |
US5599330A (en) * | 1993-11-23 | 1997-02-04 | Rainin; Edgar A. | Surgical wicking device |
US5447492A (en) | 1993-12-20 | 1995-09-05 | New Dimensions In Medicine, Inc. | External fixation dressing for accommodating a retaining pin |
US5496262A (en) | 1994-01-06 | 1996-03-05 | Aircast, Inc. | Therapeutic intermittent compression system with inflatable compartments of differing pressure from a single source |
DE4403509A1 (en) | 1994-02-04 | 1995-08-10 | Draenert Klaus | Material and process for its manufacture |
US5549584A (en) | 1994-02-14 | 1996-08-27 | The Kendall Company | Apparatus for removing fluid from a wound |
US5456267A (en) | 1994-03-18 | 1995-10-10 | Stark; John G. | Bone marrow harvesting systems and methods and bone biopsy systems and methods |
US5626861A (en) | 1994-04-01 | 1997-05-06 | Massachusetts Institute Of Technology | Polymeric-hydroxyapatite bone composite |
US6786879B1 (en) | 1994-04-05 | 2004-09-07 | Kci Licensing, Inc. | Gradient sequential compression system for preventing deep vein thrombosis |
JPH09511666A (en) | 1994-04-08 | 1997-11-25 | アトリックス・ラボラトリーズ・インコーポレイテッド | Ancillary polymer systems for use in medical devices |
US6159246A (en) | 1994-04-19 | 2000-12-12 | Mendes; David | Surgical method and tool for repairing a patella of the knee joint |
IL109344A (en) | 1994-04-19 | 1998-02-22 | Mendes David | Prosthetic patella implant of the knee joint |
GB9409281D0 (en) | 1994-05-10 | 1994-06-29 | Svedman Paul | Transdermal device |
US5556375A (en) | 1994-06-16 | 1996-09-17 | Hercules Incorporated | Wound dressing having a fenestrated base layer |
US5607388A (en) | 1994-06-16 | 1997-03-04 | Hercules Incorporated | Multi-purpose wound dressing |
PT853950E (en) | 1994-08-22 | 2003-03-31 | Kinetic Concepts Inc | WASTE DRAIN BOX |
DE4433450A1 (en) | 1994-09-20 | 1996-03-21 | Wim Dr Med Fleischmann | Device for sealing a wound area |
DE4439240A1 (en) | 1994-11-03 | 1996-05-09 | Michael Krug | Packing for elongated objects esp. folded blinds |
US5876359A (en) | 1994-11-14 | 1999-03-02 | Bock; Malcolm G. | Sequential compression device controller |
US6110197A (en) | 1994-11-21 | 2000-08-29 | Augustine Medical, Inc. | Flexible non-contact wound treatment device with a single joint |
US6093160A (en) | 1994-11-21 | 2000-07-25 | Augustine Medical, Inc. | Flexible non-contact wound treatment device |
US5817145A (en) | 1994-11-21 | 1998-10-06 | Augustine Medical, Inc. | Wound treatment device |
US5542918A (en) | 1995-01-06 | 1996-08-06 | Zimmer, Inc. | Vacuum driven fluid pump for an aspiration/irrigation instrument |
DE29504378U1 (en) | 1995-03-15 | 1995-09-14 | MTG Medizinisch, technische Gerätebau GmbH, 66299 Friedrichsthal | Electronically controlled low-vacuum pump for chest and wound drainage |
US5578022A (en) | 1995-04-12 | 1996-11-26 | Scherson; Daniel A. | Oxygen producing bandage and method |
GB9508606D0 (en) | 1995-04-27 | 1995-06-14 | Svedman Paul | Suction blister sampling |
DE19517699C2 (en) | 1995-05-13 | 1999-11-04 | Wilhelm Fleischmann | Device for vacuum sealing a wound |
GB2301362B (en) | 1995-05-30 | 1999-01-06 | Johnson & Johnson Medical | Absorbable implant materials having controlled porosity |
JP2636799B2 (en) | 1995-05-31 | 1997-07-30 | 日本電気株式会社 | Leachate suction device |
US5656027A (en) | 1995-06-06 | 1997-08-12 | Cobe Laboratories, Inc. | Surgical fluid suction accumulator and volume measurement device |
US5716360A (en) | 1995-06-30 | 1998-02-10 | U.S. Medical Products | Patella recession instrument and method for anatomically-shaped patellar prostheses |
US8282596B2 (en) | 1999-12-10 | 2012-10-09 | Medela Holding Ag | Breastpump with letdown feature |
FR2737968B1 (en) | 1995-08-23 | 1997-12-05 | Biomat | IMPLANT FOR OSTEOSYNTHESIS OF SUPERIOR FEMALE EPIPHYSIS |
EP0847376B1 (en) | 1995-09-01 | 2005-02-23 | Millenium Biologix Inc. | An artificial stabilized composition of calcium phosphate phases particularly adapted for supporting bone cell activity |
US5836311A (en) | 1995-09-20 | 1998-11-17 | Medtronic, Inc. | Method and apparatus for temporarily immobilizing a local area of tissue |
US5776193A (en) | 1995-10-16 | 1998-07-07 | Orquest, Inc. | Bone grafting matrix |
US6095148A (en) | 1995-11-03 | 2000-08-01 | Children's Medical Center Corporation | Neuronal stimulation using electrically conducting polymers |
US5733884A (en) | 1995-11-07 | 1998-03-31 | Nestec Ltd. | Enteral formulation designed for optimized wound healing |
GB9523253D0 (en) | 1995-11-14 | 1996-01-17 | Mediscus Prod Ltd | Portable wound treatment apparatus |
DE19546664C2 (en) | 1995-12-14 | 1999-02-11 | Laabs Walter | Suction device for medical purposes |
US5628735A (en) | 1996-01-11 | 1997-05-13 | Skow; Joseph I. | Surgical device for wicking and removing fluid |
US5951295A (en) | 1996-02-08 | 1999-09-14 | Materials Evolution And Development Usa, Inc. | Ceramic fused fiber enhanced dental materials |
US6087553A (en) | 1996-02-26 | 2000-07-11 | Implex Corporation | Implantable metallic open-celled lattice/polyethylene composite material and devices |
US5827246A (en) | 1996-02-28 | 1998-10-27 | Tecnol Medical Products, Inc. | Vacuum pad for collecting potentially hazardous fluids |
JP2964942B2 (en) | 1996-02-28 | 1999-10-18 | 日本電気株式会社 | Suction leachate collection device |
US5655258A (en) | 1996-03-12 | 1997-08-12 | Heintz; J. Aaron | Device for aspirating fluids from hospital operating room floor |
US5868749A (en) | 1996-04-05 | 1999-02-09 | Reed; Thomas M. | Fixation devices |
US5662625A (en) | 1996-05-06 | 1997-09-02 | Gwr Medical, L.L.P. | Pressure controllable hyperbaric device |
US6143948A (en) | 1996-05-10 | 2000-11-07 | Isotis B.V. | Device for incorporation and release of biologically active agents |
SE505000C2 (en) | 1996-05-14 | 1997-06-09 | Moelnlycke Ab | Wound dressing and manufacturing process therefore |
US6332871B1 (en) | 1996-05-17 | 2001-12-25 | Amira Medical | Blood and interstitial fluid sampling device |
US5662598A (en) | 1996-06-27 | 1997-09-02 | Tobin; Joshua M. | Silicone occlusive dressing for penetrating thoracic trauma |
US6673028B1 (en) | 1996-09-26 | 2004-01-06 | Wake Forest University Health Sciences | Passive joint movement device and method for using the same |
US5735833A (en) | 1996-12-11 | 1998-04-07 | Bristol-Myers Squibb Co. | Lavage tip |
US5810840A (en) | 1997-01-14 | 1998-09-22 | Lindsay; Richard G. | Vacuum extractor |
JP2985816B2 (en) | 1997-02-04 | 1999-12-06 | 日本電気株式会社 | Liquid sampling device |
US5941859A (en) | 1997-03-17 | 1999-08-24 | Lerman; Benjamin S. | Wound irrigation shield with fluid scavenging |
US5935136A (en) | 1997-05-09 | 1999-08-10 | Pristech, Inc. | Obstetrical vacuum extractor cup with soft molded lip |
DE19722075C1 (en) | 1997-05-27 | 1998-10-01 | Wilhelm Dr Med Fleischmann | Medication supply to open wounds |
DE59809764D1 (en) | 1997-05-27 | 2003-11-06 | Wilhelm Fleischmann | Device for applying active substances to a wound surface |
US7759538B2 (en) | 1997-05-27 | 2010-07-20 | Wilhelm Fleischmann | Process and device for application of active substances to a wound surface |
US6484716B1 (en) | 1997-07-22 | 2002-11-26 | Kci Licensing, Inc. | Hyperbaric oxygen patient treatment system with therapeutic surface |
US6135116A (en) | 1997-07-28 | 2000-10-24 | Kci Licensing, Inc. | Therapeutic method for treating ulcers |
US7214202B1 (en) | 1997-07-28 | 2007-05-08 | Kci Licensing, Inc. | Therapeutic apparatus for treating ulcers |
US6420622B1 (en) | 1997-08-01 | 2002-07-16 | 3M Innovative Properties Company | Medical article having fluid control film |
US6080243A (en) | 1998-06-18 | 2000-06-27 | 3M Innovative Properties Company | Fluid guide device having an open structure surface for attachement to a fluid transport source |
US6290685B1 (en) | 1998-06-18 | 2001-09-18 | 3M Innovative Properties Company | Microchanneled active fluid transport devices |
GB9719520D0 (en) | 1997-09-12 | 1997-11-19 | Kci Medical Ltd | Surgical drape and suction heads for wound treatment |
US7273054B2 (en) | 1997-09-12 | 2007-09-25 | Kci Licensing, Inc. | Surgical drape and head for wound treatment |
US5919476A (en) | 1997-09-29 | 1999-07-06 | Pmt Corporation | Reinforced gel sheeting for scar treatment |
WO1999018892A1 (en) | 1997-10-09 | 1999-04-22 | Cambridge Scientific, Inc. | Biodegradable, biopolymeric bioelectret implant for tissue regeneration |
US6106913A (en) | 1997-10-10 | 2000-08-22 | Quantum Group, Inc | Fibrous structures containing nanofibrils and other textile fibers |
US6053416A (en) | 1997-10-29 | 2000-04-25 | Kci Industries, Inc. | Automatic hydronic zone valve and electric controls therefor |
US5928174A (en) | 1997-11-14 | 1999-07-27 | Acrymed | Wound dressing device |
US6712851B1 (en) | 1998-01-23 | 2004-03-30 | Macropore Biosurgery, Inc. | Resorbable, macro-porous non-collapsing and flexible membrane barrier for skeletal repair and regeneration |
US6071267A (en) | 1998-02-06 | 2000-06-06 | Kinetic Concepts, Inc. | Medical patient fluid management interface system and method |
WO1999051164A1 (en) | 1998-04-03 | 1999-10-14 | Reprogenesis, Inc. | Soft tissue reconstructor and method of use |
US6080189A (en) | 1998-04-06 | 2000-06-27 | Augustine Medical, Inc. | Wound treatment apparatus including a heater and an IR-Transparent or IR-Transmissive bandage |
US6095992A (en) | 1998-04-06 | 2000-08-01 | Augustine Medical, Inc. | Wound treatment apparatus for normothermic treatment of wounds |
US6235047B1 (en) | 1998-04-06 | 2001-05-22 | Augustine Medical, Inc. | Wound treatment apparatus with a heater, a heat conductive bandage, and heat-spreading means acting between the heater and bandage |
US6213965B1 (en) | 1998-04-06 | 2001-04-10 | Augustine Medical, Inc. | Wound treatment apparatus with infrared absorptive wound cover |
US6071304A (en) | 1998-04-06 | 2000-06-06 | Augustine Medical, Inc. | Wound treatment apparatus with a heater adhesively joined to a bandage |
US6143945A (en) | 1998-04-06 | 2000-11-07 | Augustine Medical, Inc. | Bandage for autolytic wound debridement |
US6086587A (en) | 1998-07-10 | 2000-07-11 | Hawk; Rodney | Multi-head suction assembly for use in surgical procedures |
US6458109B1 (en) | 1998-08-07 | 2002-10-01 | Hill-Rom Services, Inc. | Wound treatment apparatus |
US6325788B1 (en) | 1998-09-16 | 2001-12-04 | Mckay Douglas William | Treatment of wound or joint for relief of pain and promotion of healing |
US7662409B2 (en) | 1998-09-25 | 2010-02-16 | Gel-Del Technologies, Inc. | Protein matrix materials, devices and methods of making and using thereof |
US6488643B1 (en) | 1998-10-08 | 2002-12-03 | Kci Licensing, Inc. | Wound healing foot wrap |
GB9822341D0 (en) | 1998-10-13 | 1998-12-09 | Kci Medical Ltd | Negative pressure therapy using wall suction |
US6284832B1 (en) | 1998-10-23 | 2001-09-04 | Pirelli Cables And Systems, Llc | Crosslinked conducting polymer composite materials and method of making same |
AU1133600A (en) | 1998-10-29 | 2000-05-22 | Agion Technologies, Llc | Antimicrobial plastic closures for drinking containers |
US6296863B1 (en) | 1998-11-23 | 2001-10-02 | Agion Technologies, Llc | Antimicrobial fabric and medical graft of the fabric |
US6585767B1 (en) | 1998-11-23 | 2003-07-01 | Agion Technologies, Inc. | Antimicrobial suturing ring for heart valve |
US6767334B1 (en) | 1998-12-23 | 2004-07-27 | Kci Licensing, Inc. | Method and apparatus for wound treatment |
AU2713800A (en) | 1998-12-23 | 2000-07-31 | Kci Licensing, Inc. | Method and apparatus for wound treatment |
WO2000038552A1 (en) | 1998-12-31 | 2000-07-06 | Healthshield Technologies Llc | Antimicrobial contact lens case |
DE19901134C2 (en) | 1999-01-14 | 2002-11-21 | Wilhelm Fleischmann | dressing material |
US6146423A (en) | 1999-01-28 | 2000-11-14 | Implex Corporation | Patella replacement apparatus |
US6430427B1 (en) | 1999-02-25 | 2002-08-06 | Electronics And Telecommunications Research Institute | Method for obtaining trabecular index using trabecular pattern and method for estimating bone mineral density using trabecular indices |
US6284941B1 (en) | 1999-03-09 | 2001-09-04 | Craig M. Cox | Bandage having a scar treatment pad for scar management and scar repair |
US6355215B1 (en) | 1999-03-10 | 2002-03-12 | Implex Corp. | Wear-resistant olefinic medical implant and thermal treatment container therefor |
US6395007B1 (en) | 1999-03-16 | 2002-05-28 | American Osteomedix, Inc. | Apparatus and method for fixation of osteoporotic bone |
US6051016A (en) | 1999-03-29 | 2000-04-18 | Instrumed, Inc. | System and method of controlling pressure in a surgical tourniquet |
WO2000059424A1 (en) | 1999-04-02 | 2000-10-12 | Kinetic Concepts, Inc. | Vacuum assisted closure system with provision for introduction of agent |
US20070014837A1 (en) | 1999-04-02 | 2007-01-18 | Kci Licensing, Inc. | System and method for use of agent in combination with subatmospheric pressure tissue treatment |
US20070021697A1 (en) | 2004-07-26 | 2007-01-25 | Kci Licensing, Inc. | System and method for use of agent in combination with subatmospheric tissue treatment |
DK1164986T3 (en) | 1999-04-02 | 2007-01-08 | Kci Licensing Inc | Vacuum-assisted closure system with heating and cooling measures |
US7947033B2 (en) | 1999-04-06 | 2011-05-24 | Kci Licensing Inc. | Systems and methods for detection of wound fluid blood and application of phototherapy in conjunction with reduced pressure wound treatment system |
US6994702B1 (en) | 1999-04-06 | 2006-02-07 | Kci Licensing, Inc. | Vacuum assisted closure pad with adaptation for phototherapy |
US7799004B2 (en) | 2001-03-05 | 2010-09-21 | Kci Licensing, Inc. | Negative pressure wound treatment apparatus and infection identification system and method |
US6856821B2 (en) | 2000-05-26 | 2005-02-15 | Kci Licensing, Inc. | System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure |
US6695823B1 (en) | 1999-04-09 | 2004-02-24 | Kci Licensing, Inc. | Wound therapy device |
WO2000061206A1 (en) | 1999-04-09 | 2000-10-19 | Kci Licensing, Inc. | Wound therapy device |
GB9909301D0 (en) | 1999-04-22 | 1999-06-16 | Kci Medical Ltd | Wound treatment apparatus employing reduced pressure |
US6203563B1 (en) | 1999-05-26 | 2001-03-20 | Ernesto Ramos Fernandez | Healing device applied to persistent wounds, fistulas, pancreatitis, varicose ulcers, and other medical or veterinary pathologies of a patient |
US6447491B1 (en) | 1999-06-18 | 2002-09-10 | Genzyme Corporation | Rolling seal suction pressure regulator, apparatus and system for draining a body cavity and methods related thereto |
AU782297B2 (en) | 1999-06-30 | 2005-07-14 | Ethicon Inc. | Porous tissue scaffoldings for the repair or regeneration of tissue |
US6306424B1 (en) | 1999-06-30 | 2001-10-23 | Ethicon, Inc. | Foam composite for the repair or regeneration of tissue |
US6190391B1 (en) | 1999-10-01 | 2001-02-20 | Bristol-Myers Squibb Company | Method of preparing a resected posterior surface of a patella to receive a prosthetic element |
GB9926538D0 (en) | 1999-11-09 | 2000-01-12 | Kci Medical Ltd | Multi-lumen connector |
US6764462B2 (en) | 2000-11-29 | 2004-07-20 | Hill-Rom Services Inc. | Wound treatment apparatus |
US6824533B2 (en) | 2000-11-29 | 2004-11-30 | Hill-Rom Services, Inc. | Wound treatment apparatus |
HUP0500055A2 (en) | 1999-11-29 | 2005-07-28 | Hill-Rom Services, Inc. | Wound treatment apparatus |
US6491693B1 (en) | 1999-12-07 | 2002-12-10 | Michael Lytinas | Method of promoting osteogenesis by application of a vacuum to affected bone areas, and device for same |
KR100343777B1 (en) | 1999-12-10 | 2002-07-20 | 한국전자통신연구원 | Method for calibrating trabecular index using sawtooth-shaped rack |
US6528697B1 (en) | 2000-01-03 | 2003-03-04 | Augustine Medical, Inc. | Modular bandage |
US6682491B2 (en) | 2000-02-11 | 2004-01-27 | Kci Licensing, Inc. | Method for artifact reduction in intracranial pressure measurements |
US6641604B1 (en) | 2000-02-11 | 2003-11-04 | Iotek, Inc. | Devices and method for manipulation of organ tissue |
RU2186541C2 (en) * | 2000-05-03 | 2002-08-10 | Самарский государственный медицинский университет | Method for stabilizing the mobile vertebral segment in case of surgical correction of spondilolisthesis |
GB0011202D0 (en) | 2000-05-09 | 2000-06-28 | Kci Licensing Inc | Abdominal wound dressing |
US6485503B2 (en) | 2000-05-19 | 2002-11-26 | Coapt Systems, Inc. | Multi-point tissue tension distribution device, a brow and face lift variation, and a method of tissue approximation using the device |
WO2001089431A1 (en) | 2000-05-22 | 2001-11-29 | Coffey Arthur C | Combination sis and vacuum bandage and method |
ATE520355T1 (en) | 2000-06-07 | 2011-09-15 | Aircast Inc | METHOD AND DEVICE FOR SIMPLIFYING BONE Fracture Healing |
US6520982B1 (en) | 2000-06-08 | 2003-02-18 | Kci Licensing, Inc. | Localized liquid therapy and thermotherapy device |
US6685681B2 (en) | 2000-11-29 | 2004-02-03 | Hill-Rom Services, Inc. | Vacuum therapy and cleansing dressing for wounds |
US6855135B2 (en) | 2000-11-29 | 2005-02-15 | Hill-Rom Services, Inc. | Vacuum therapy and cleansing dressing for wounds |
US20020084178A1 (en) * | 2000-12-19 | 2002-07-04 | Nicast Corporation Ltd. | Method and apparatus for manufacturing polymer fiber shells via electrospinning |
CA2433550A1 (en) | 2001-01-02 | 2002-07-11 | Advanced Ceramics Research, Inc. | Compositions and methods for biomedical applications |
DE10102317A1 (en) | 2001-01-19 | 2002-08-14 | Hmt Ag | Method and device for applying pressure waves to the body of a living being |
US7763769B2 (en) | 2001-02-16 | 2010-07-27 | Kci Licensing, Inc. | Biocompatible wound dressing |
US7700819B2 (en) * | 2001-02-16 | 2010-04-20 | Kci Licensing, Inc. | Biocompatible wound dressing |
US7070584B2 (en) | 2001-02-20 | 2006-07-04 | Kci Licensing, Inc. | Biocompatible wound dressing |
US6663349B1 (en) | 2001-03-02 | 2003-12-16 | Reliance Electric Technologies, Llc | System and method for controlling pump cavitation and blockage |
US7108683B2 (en) | 2001-04-30 | 2006-09-19 | Kci Licensing, Inc | Wound therapy and tissue management system and method with fluid differentiation |
AU2002315027A1 (en) * | 2001-05-15 | 2002-11-25 | Children's Medical Center Corporation | Methods and apparatus for application of micro-mechanical forces to tissues |
EP2204213B2 (en) | 2001-07-12 | 2020-04-01 | KCI Licensing, Inc. | Control of vacuum level rate of change |
EP1406561A4 (en) | 2001-07-16 | 2008-03-12 | Edwards Lifesciences Corp | Tissue engineered heart valve |
US7004915B2 (en) | 2001-08-24 | 2006-02-28 | Kci Licensing, Inc. | Negative pressure assisted tissue treatment system |
AUPR773901A0 (en) | 2001-09-18 | 2001-10-11 | University Of Queensland, The | Fracture cuff |
WO2003026489A2 (en) | 2001-09-28 | 2003-04-03 | University Of Florida | Biopolymer and biopolymer-cell compositions for nerve tissue repair |
SE524111C2 (en) | 2001-09-28 | 2004-06-29 | Jan Otto Solem | A method and device for organ recovery |
US20030077564A1 (en) * | 2001-10-02 | 2003-04-24 | Board Of Trustees Of Southern Illinois University | Nutrient medium for maintaining neural cells in injured nervous system |
US7722894B2 (en) | 2001-10-22 | 2010-05-25 | Massachusetts Institute Of Technology | Biodegradable polymer |
US6648862B2 (en) | 2001-11-20 | 2003-11-18 | Spheric Products, Ltd. | Personally portable vacuum desiccator |
US20030219469A1 (en) | 2002-02-11 | 2003-11-27 | Kci Licensing, Inc. | Environmental control device for tissue treatment |
US6942633B2 (en) | 2002-03-22 | 2005-09-13 | Twin Star Medical, Inc. | System for treating tissue swelling |
US20040225178A1 (en) | 2002-05-21 | 2004-11-11 | Kriewall Timothy J. | Apparatus and methods for treating symptoms of disease and conditions of the ear |
WO2003101508A2 (en) | 2002-05-31 | 2003-12-11 | Hill-Rom Services, Inc. | Wound treatment apparatus |
US20030225347A1 (en) | 2002-06-03 | 2003-12-04 | Argenta Louis C. | Directed tissue growth employing reduced pressure |
US7066960B1 (en) | 2002-06-28 | 2006-06-27 | Dickman Curtis A | Intervertebral disk replacement |
US7381211B2 (en) | 2002-08-21 | 2008-06-03 | Kci Licensing, Inc. | Medical closure screen device and method |
US7410495B2 (en) | 2002-08-21 | 2008-08-12 | Kci Licensing, Inc. | Medical closure clip system and method |
US7413571B2 (en) | 2002-08-21 | 2008-08-19 | Kci Licensing, Inc. | Flexible medical closure screen and method |
US7351250B2 (en) | 2002-08-21 | 2008-04-01 | Kci Licensing, Inc. | Circumferential medical closure device and method |
US7413570B2 (en) | 2002-08-21 | 2008-08-19 | Kci Licensing, Inc. | Medical closure screen installation systems and methods |
US20040039391A1 (en) | 2002-08-23 | 2004-02-26 | Argenta Louis C. | Bone treatment employing reduced pressure |
US20040122434A1 (en) | 2002-08-23 | 2004-06-24 | Argenta Louis C. | Bone treatment employing reduced pressure |
US7846141B2 (en) | 2002-09-03 | 2010-12-07 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
US7815616B2 (en) | 2002-09-16 | 2010-10-19 | Boehringer Technologies, L.P. | Device for treating a wound |
US7625362B2 (en) | 2003-09-16 | 2009-12-01 | Boehringer Technologies, L.P. | Apparatus and method for suction-assisted wound healing |
US6840960B2 (en) | 2002-09-27 | 2005-01-11 | Stephen K. Bubb | Porous implant system and treatment method |
US20060121080A1 (en) | 2002-11-13 | 2006-06-08 | Lye Whye K | Medical devices having nanoporous layers and methods for making the same |
US7175625B2 (en) | 2002-11-25 | 2007-02-13 | Triage Medical | Soft tissue anchor and method of using same |
US20040127845A1 (en) | 2002-12-27 | 2004-07-01 | Playtex Products, Inc. | Breast pump system |
US7976519B2 (en) | 2002-12-31 | 2011-07-12 | Kci Licensing, Inc. | Externally-applied patient interface system and method |
US6951553B2 (en) | 2002-12-31 | 2005-10-04 | Kci Licensing, Inc | Tissue closure treatment system and method with externally-applied patient interface |
US20040210009A1 (en) | 2003-01-31 | 2004-10-21 | Sadayuki Kobayashi | Polymer alloy and method for manufacturing polymer alloy |
US7169151B1 (en) | 2003-04-10 | 2007-01-30 | Kci Licensing, Inc. | Bone regeneration device for long bones, and method of use |
CN1822874B (en) | 2003-07-22 | 2010-10-13 | 凯希特许有限公司 | Negative pressure wound treatment dressing |
US7942866B2 (en) | 2003-08-28 | 2011-05-17 | Boehringer Technologies, L.P. | Device for treating a wound |
DE10342071B4 (en) | 2003-09-10 | 2006-01-19 | Fleischmann, Wilhelm, Dr.med. | Device and method for applying substances to a wound surface |
US20050065484A1 (en) | 2003-09-10 | 2005-03-24 | Watson Richard L. | Wound healing apparatus with bioabsorbable material and suction tubes |
US20090325859A1 (en) | 2003-09-19 | 2009-12-31 | Northwestern University | Citric acid polymers |
WO2005028631A2 (en) | 2003-09-19 | 2005-03-31 | Northwestern University | A novel biodegradable elastomeric scaffold for tissue engineering and light scattering fingerprinting methods for testing the same |
EP1691856A2 (en) | 2003-10-14 | 2006-08-23 | Cube Medical A/S | Medical device with electrospun nanofibers |
GB0325130D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with scaffold |
US7887510B2 (en) | 2003-12-08 | 2011-02-15 | Boehringer Laboratories, Inc. | Suction control apparatus and methods for maintaining fluid flow without compromising sterile lines |
US7128735B2 (en) | 2004-01-02 | 2006-10-31 | Richard Scott Weston | Reduced pressure wound treatment appliance |
US7270647B2 (en) | 2004-03-04 | 2007-09-18 | Boehringer Technologies, L.P. | Apparatus for vacuum-assisted irrigation and drainage of a body cavity |
US8100887B2 (en) | 2004-03-09 | 2012-01-24 | Bluesky Medical Group Incorporated | Enclosure-based reduced pressure treatment system |
US7754937B2 (en) | 2004-03-18 | 2010-07-13 | Boehringer Technologies, L.P. | Wound packing material for use with suction |
US8062272B2 (en) | 2004-05-21 | 2011-11-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US7708724B2 (en) | 2004-04-05 | 2010-05-04 | Blue Sky Medical Group Incorporated | Reduced pressure wound cupping treatment system |
US7776028B2 (en) | 2004-04-05 | 2010-08-17 | Bluesky Medical Group Incorporated | Adjustable overlay reduced pressure wound treatment system |
US7909805B2 (en) | 2004-04-05 | 2011-03-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US7884258B2 (en) | 2004-04-13 | 2011-02-08 | Boehringer Technologies, L.P. | Wound contact device |
GB0424046D0 (en) | 2004-10-29 | 2004-12-01 | Smith & Nephew | Apparatus |
GB0508528D0 (en) * | 2005-04-27 | 2005-06-01 | Smith & Nephew | SAI with macrostress |
US7998125B2 (en) | 2004-05-21 | 2011-08-16 | Bluesky Medical Group Incorporated | Hypobaric chamber treatment system |
WO2006014917A2 (en) | 2004-07-26 | 2006-02-09 | Kci Licensing, Inc. | Method for coating substrate with antimicrobial agent and product formed thereby |
US8172857B2 (en) | 2004-08-27 | 2012-05-08 | Davol, Inc. | Endoscopic tissue apposition device and method of use |
US7485112B2 (en) | 2004-11-08 | 2009-02-03 | Boehringer Technologies, L.P. | Tube attachment device for wound treatment |
US20080102054A1 (en) * | 2005-01-18 | 2008-05-01 | Faustman Denise L | Compositions Containing Agm Cells And Methods Of Use Thereof |
US20060293169A1 (en) | 2005-02-09 | 2006-12-28 | General Electric Company | Molecular structures for gas sensing and devices and methods therewith |
US8048446B2 (en) | 2005-05-10 | 2011-11-01 | Drexel University | Electrospun blends of natural and synthetic polymer fibers as tissue engineering scaffolds |
WO2006138718A2 (en) | 2005-06-17 | 2006-12-28 | Drexel University | Three-dimensional scaffolds for tissue engineering made by processing complex extracts of natural extracellular matrices |
US20070155010A1 (en) | 2005-07-29 | 2007-07-05 | Farnsworth Ted R | Highly porous self-cohered fibrous tissue engineering scaffold |
US20070032754A1 (en) | 2005-08-02 | 2007-02-08 | Walsh Richard F | Method and apparatus for treating a wound |
US20070071790A1 (en) | 2005-09-28 | 2007-03-29 | Northwestern University | Biodegradable nanocomposites with enhance mechanical properties for soft tissue |
GB0524027D0 (en) | 2005-11-25 | 2006-01-04 | Smith & Nephew | Fibrous dressing |
CN101384285B (en) | 2005-12-06 | 2013-09-18 | 凯希特许有限公司 | Wound exudate removal and isolation system |
US20090011486A1 (en) | 2006-01-12 | 2009-01-08 | Massachusetts Institute Of Technology | Biodegradable Elastomers |
US20070208420A1 (en) | 2006-02-08 | 2007-09-06 | Northwestern University | Functionalizing implantable devices with a poly (diol co-citrate) polymer |
US8029498B2 (en) | 2006-03-14 | 2011-10-04 | Kci Licensing Inc. | System for percutaneously administering reduced pressure treatment using balloon dissection |
CA2646241C (en) * | 2006-03-14 | 2012-10-09 | Kci Licensing, Inc. | System and method for purging a reduced pressure apparatus during the administration of reduced pressure treatment |
US8974542B2 (en) | 2006-06-27 | 2015-03-10 | University of Pittsburgh—of the Commonwealth System of Higher Education | Biodegradable elastomeric patch for treating cardiac or cardiovascular conditions |
AU2007281996B2 (en) | 2006-08-04 | 2013-06-27 | Stb, Ltd | Solid dressing for treating wounded tissue |
JP2008099565A (en) | 2006-10-17 | 2008-05-01 | Koken Co Ltd | Sponge-like sheet for culturing cardiac muscle |
US20080103489A1 (en) | 2006-10-26 | 2008-05-01 | The University Of North Carolina At Chapel Hill | Vacuum adherent dressings, systems and methods of use for same |
US20080112998A1 (en) | 2006-11-14 | 2008-05-15 | Hongjun Wang | Innovative bottom-up cell assembly approach to three-dimensional tissue formation using nano-or micro-fibers |
US7931651B2 (en) | 2006-11-17 | 2011-04-26 | Wake Lake University Health Sciences | External fixation assembly and method of use |
JP5433420B2 (en) | 2006-12-06 | 2014-03-05 | スパイナル・モデュレーション・インコーポレイテッド | Collective lead for spinal cord stimulation |
GB0625964D0 (en) * | 2006-12-23 | 2007-02-07 | Renovo Ltd | Promotion of wound contraction |
US8377016B2 (en) | 2007-01-10 | 2013-02-19 | Wake Forest University Health Sciences | Apparatus and method for wound treatment employing periodic sub-atmospheric pressure |
US20080208171A1 (en) | 2007-02-23 | 2008-08-28 | Argenta Louis C | Device and method for removing edema |
EP3513820A1 (en) | 2007-03-14 | 2019-07-24 | The Board of Trustees of the Leland Stanford University | Devices for application of reduced pressure therapy |
AU2008262140B2 (en) | 2007-05-24 | 2014-04-24 | Applied Tissue Technologies Llc | Wound treatment device employing negative pressure |
RU70627U1 (en) | 2007-09-17 | 2008-02-10 | Вадим Владимирович Белов | DEVICE FOR VACUUM THERAPY OF PURULENT RAS |
US7923486B2 (en) | 2007-10-04 | 2011-04-12 | Board Of Regents, The University Of Texas System | Bio-polymer and scaffold-sheet method for tissue engineering |
BRPI0817544A2 (en) | 2007-10-10 | 2017-05-02 | Univ Wake Forest Health Sciences | apparatus for treating damaged spinal cord tissue |
CN102014980B (en) | 2008-01-09 | 2014-04-09 | 韦克福里斯特大学健康科学院 | Device and method for treating central nervous system pathology |
US20110129436A1 (en) | 2008-02-15 | 2011-06-02 | The General Hospital Corporation | Polyglycerol sebecate peritoneal adhesion prevention barrier |
US8248305B2 (en) | 2008-06-03 | 2012-08-21 | University Of Houston | Antennas based on a conductive polymer composite and methods for production thereof |
ES2633142T3 (en) | 2008-07-18 | 2017-09-19 | Wake Forest University Health Sciences | Apparatus for modulation of cardiac tissue through topical application of vacuum to minimize death and cell damage |
GB0816496D0 (en) | 2008-09-10 | 2008-10-15 | Zhao Xiaobin | Hyaluronic acid cryogel |
US20100221304A1 (en) | 2009-02-26 | 2010-09-02 | The Regents Of The University Of Colorado, A Body Corporate | Bionanocomposite Materials and Methods For Producing and Using the Same |
US20110008406A1 (en) | 2009-04-20 | 2011-01-13 | Altman Gregory H | Silk Fibroin Hydrogels and Uses Thereof |
AU2010286604A1 (en) | 2009-08-28 | 2012-03-08 | Innovative Health Technologies, Llc | Polymer adhesive film for directed cellular growth |
WO2012004627A1 (en) | 2010-07-09 | 2012-01-12 | Indian Institute Of Technology Madras | Nerve guide conduit containing carbon nanotubes |
US9168231B2 (en) | 2010-12-05 | 2015-10-27 | Nanonerve, Inc. | Fibrous polymer scaffolds having diametrically patterned polymer fibers |
-
2008
- 2008-10-09 BR BRPI0817544A patent/BRPI0817544A2/en not_active IP Right Cessation
- 2008-10-09 RU RU2010118021/14A patent/RU2489993C2/en not_active IP Right Cessation
- 2008-10-09 WO PCT/US2008/079364 patent/WO2009049058A1/en active Application Filing
- 2008-10-09 CN CN200880121075.8A patent/CN101896140B/en not_active Expired - Fee Related
- 2008-10-09 CA CA2702239A patent/CA2702239C/en active Active
- 2008-10-09 JP JP2010529042A patent/JP5462175B2/en active Active
- 2008-10-09 KR KR1020107010720A patent/KR101600041B1/en active IP Right Grant
- 2008-10-09 ES ES08837309.7T patent/ES2661762T3/en active Active
- 2008-10-09 US US12/248,346 patent/US8834520B2/en active Active
- 2008-10-09 AU AU2008310819A patent/AU2008310819B2/en active Active
- 2008-10-09 DK DK08837309.7T patent/DK2205189T3/en active
- 2008-10-09 EP EP08837309.7A patent/EP2205189B1/en active Active
-
2010
- 2010-04-06 IL IL204825A patent/IL204825A/en active IP Right Grant
- 2010-04-09 ZA ZA2010/02498A patent/ZA201002498B/en unknown
-
2011
- 2011-05-23 HK HK11105095.0A patent/HK1150958A1/en unknown
-
2014
- 2014-08-13 US US14/458,790 patent/US20140350499A1/en not_active Abandoned
-
2017
- 2017-09-11 US US15/700,667 patent/US10632235B2/en active Active
-
2020
- 2020-04-08 US US16/842,935 patent/US20200384168A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IL204825A (en) | 2014-04-30 |
EP2205189B1 (en) | 2017-12-06 |
ZA201002498B (en) | 2011-01-26 |
US20170368242A1 (en) | 2017-12-28 |
JP2011500163A (en) | 2011-01-06 |
KR20100100798A (en) | 2010-09-15 |
US20090187259A1 (en) | 2009-07-23 |
KR101600041B1 (en) | 2016-03-03 |
CA2702239A1 (en) | 2009-04-16 |
HK1150958A1 (en) | 2012-01-20 |
RU2489993C2 (en) | 2013-08-20 |
EP2205189A4 (en) | 2015-08-26 |
CA2702239C (en) | 2016-11-08 |
IL204825A0 (en) | 2010-11-30 |
US10632235B2 (en) | 2020-04-28 |
WO2009049058A1 (en) | 2009-04-16 |
AU2008310819A1 (en) | 2009-04-16 |
AU2008310819B2 (en) | 2013-06-27 |
US20200384168A1 (en) | 2020-12-10 |
JP5462175B2 (en) | 2014-04-02 |
DK2205189T3 (en) | 2018-03-12 |
ES2661762T3 (en) | 2018-04-03 |
US20140350499A1 (en) | 2014-11-27 |
EP2205189A1 (en) | 2010-07-14 |
US8834520B2 (en) | 2014-09-16 |
CN101896140A (en) | 2010-11-24 |
RU2010118021A (en) | 2011-11-20 |
BRPI0817544A2 (en) | 2017-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101896140B (en) | Devices and methods for treating spinal cord tissue | |
RU2517588C2 (en) | Device and method for treating pathologies of central nervous system | |
KR102129562B1 (en) | Method and composition for treating inflammatory bowel disease without colectomy | |
US9655948B1 (en) | Non-surgical, localized delivery of compositions for placental growth factors | |
Moreland | Collection and withdrawal of body fluids and infusion techniques | |
KR20130025337A (en) | Adhesion-preventing agent and method for preventing adhesion using the same | |
Lacasse | Falconiformes (falcons, hawks, eagles, kites, harriers, buzzards, ospreys, caracaras, secretary birds, Old World and New World vultures) | |
CN104368043B (en) | A kind of collagen stroma repair of cartilage film, preparation method and application | |
CN103705910A (en) | Ziconotide injection hypodermic implant and preparation method thereof | |
CN116421618A (en) | Preparation method of Se@NADH and application of Se@NADH in spinal cord injury treatment | |
CN114573839B (en) | Preparation method of human hair keratin/chitosan hydrogel loaded with curcumin | |
CN101020049A (en) | Use of ulinastatin in preparing medicine for treating and/or preventing spinal cord injury | |
CN105363073A (en) | Tissue engineering cartilage stent containing bioactive factor as well as preparation method and application of tissue engineering cartilage stent | |
WO2015157027A1 (en) | Fibrous component for health, performance, and aesthetic treatment | |
AU2013202873B2 (en) | Devices and methods for treating spinal cord tissue | |
Malyuk et al. | Influence of autological growth factors on activation of regenerative processes of the superficial digital flexor tendon of horses | |
Esterowitz et al. | Plantar warts in the athlete | |
Park et al. | Treatment of bilateral corneal ulceration in a Peregrine Falcon (Falco peregrinus) using 360 degree conjunctival flaps | |
Dijk | Pilot study to test attachment of repair tissue to a non-resorbable osteochondral implant with vertical channels | |
CN103505301A (en) | Rat spinal cord full-transection injury model and method for establishing rat spinal cord full-transection damage model | |
KR19990037907A (en) | Acupuncture therapy of sow mastitis by honeybee venom | |
Robinson et al. | The use of a chitosan-based hyaluronate gel in musculoskeletal afflictions | |
Hopper | Treatment Options for Hindlimb Proximal Suspensory Desmitis | |
Johnson | Surgical techniques | |
Clark | Studies on the physiology of the reticulum and rumen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1150958 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140108 Termination date: 20151009 |
|
EXPY | Termination of patent right or utility model |